The Healthcare sector includes companies that provide medical services, manufacture medical equipment and drugs, and develop biotechnologies and healthcare solutions. This sector spans a wide range of industries, from pharmaceutical companies and biotechnology firms to healthcare providers, hospitals, and medical device manufacturers. The healthcare sector is considered defensive, as demand for medical care remains constant regardless of the economic environment. Examples include pharmaceutical companies, medical device manufacturers, and healthcare providers.
Sector Read
Coverage Overview
A quick read on breadth, benchmark scope, and data participation.
Median pillar scores with the sector middle band for a quick read on quality, resilience, and valuation posture. Based on 2025.
Growth
Sample 325
Profitability
Sample 325
Health
Sample 325
Efficiency
Sample 325
Valuation
Sample 321
Distribution bands and center points across 1266 contributing companies. Use the tooltip for quartiles, completeness, and freshness, then compare those norms against the leaderboard cards below.
Trend highlights are prioritised around Cash Runway, Operating Margin for this sector.
Latest composite and moat snapshots, plus two sector-relevant benchmark metrics chosen for Healthcare. Tracking Cash Runway and Operating Margin.
Scan scale, positioning, and latest annual metric momentum across the sector without leaving the benchmark view.
| Company | Market Cap | Positioning |
Cash Runway
Latest annual + YoY
|
Operating Margin
Latest annual + YoY
|
|---|---|---|---|---|
|
1.04T
|
Composite
45.0
Moat
48.6
|
-
No YoY
|
5.1%
-33.8
YoY
|
|
|
556.77B
|
Composite
47.6
Moat
81.3
|
-
No YoY
|
27.2%
+2.2
YoY
|
|
|
ABBV
AbbVie Inc.
|
406.38B
|
Composite
52.5
Moat
70.3
|
-
No YoY
|
34.7%
+13.6
YoY
|
|
369.32B
|
Composite
57.0
Moat
52.7
|
-
No YoY
|
4.2%
-3.8
YoY
|
|
|
285.22B
|
Composite
52.5
Moat
78.0
|
-
No YoY
|
41.2%
+9.7
YoY
|
|
|
NVS
Novartis AG
|
284.17B
|
Composite
56.5
Moat
79.0
|
-
No YoY
|
31.1%
+3.0
YoY
|
|
AZN
Astrazeneca PLC
|
273.29B
|
Composite
46.1
Moat
73.9
|
-
No YoY
|
23.4%
+4.9
YoY
|
|
NVO
Novo Nordisk A/S
|
204.85B
|
Composite
56.1
Moat
81.8
|
-
No YoY
|
41.3%
-2.9
YoY
|
|
AMGN
Amgen Inc.
|
186.05B
|
Composite
53.9
Moat
71.2
|
-
No YoY
|
24.7%
+3.0
YoY
|
|
172.44B
|
Composite
64.3
Moat
58.8
|
-
No YoY
|
18.2%
+0.2
YoY
|
|
|
155.03B
|
Composite
59.8
Moat
81.5
|
-
No YoY
|
40.1%
+3.6
YoY
|
|
|
153.99B
|
Composite
70.6
Moat
73.2
|
-
No YoY
|
18.2%
+1.9
YoY
|
|
|
PFE
Pfizer, Inc.
|
142.94B
|
Composite
40.6
Moat
63.0
|
-
No YoY
|
24.7%
+1.4
YoY
|
|
142.71B
|
Composite
67.7
Moat
82.5
|
-
No YoY
|
29.3%
+1.2
YoY
|
|
|
129.25B
|
Composite
51.6
Moat
35.3
|
-
No YoY
|
2.6%
+0.3
YoY
|
|
|
125.40B
|
Composite
67.1
Moat
70.8
|
-
No YoY
|
20.9%
+0.5
YoY
|
|
|
118.47B
|
Composite
69.9
Moat
81.2
|
149.0
No YoY
|
38.0%
+40.1
YoY
|
|
|
116.81B
|
Composite
74.0
Moat
74.5
|
-
No YoY
|
20.1%
-0.5
YoY
|
|
|
110.27B
|
Composite
48.0
Moat
76.6
|
-
No YoY
|
28.5%
+16.3
YoY
|
|
|
GSK
GSK plc
|
102.06B
|
Composite
47.4
Moat
71.1
|
-
No YoY
|
21.9%
+4.3
YoY
|
|
SNY
Sanofi
|
101.90B
|
Composite
44.3
Moat
69.0
|
-
No YoY
|
13.6%
-7.8
YoY
|
|
MDT
Medtronic plc.
|
101.47B
|
Composite
70.4
Moat
72.7
|
-
No YoY
|
19.5%
+2.4
YoY
|
|
89.53B
|
Composite
54.4
Moat
50.0
|
-
No YoY
|
1.2%
-0.1
YoY
|
|
|
85.74B
|
Composite
50.3
Moat
58.9
|
-
No YoY
|
4.1%
-1.1
YoY
|
|
|
83.23B
|
Composite
57.2
Moat
66.7
|
-
No YoY
|
15.8%
+0.9
YoY
|
|
|
74.62B
|
Composite
53.1
Moat
54.2
|
-
No YoY
|
3.0%
+0.2
YoY
|
|
|
65.89B
|
Composite
70.7
Moat
77.7
|
-
No YoY
|
19.8%
+1.9
YoY
|
|
|
64.21B
|
Composite
70.1
Moat
80.0
|
-
No YoY
|
25.8%
-2.3
YoY
|
|
|
ARGX
argenx SE
|
55.93B
|
Composite
68.4
Moat
78.0
|
490.0
+399.2
YoY
|
25.4%
+26.2
YoY
|
|
COR
Cencora, Inc.
|
52.78B
|
Composite
53.6
Moat
52.0
|
-
No YoY
|
1.2%
+0.2
YoY
|
|
52.17B
|
Composite
53.2
Moat
47.3
|
-
No YoY
|
1.0%
+0.1
YoY
|
|
|
49.45B
|
Composite
66.4
Moat
78.3
|
-
No YoY
|
27.0%
-0.2
YoY
|
|
|
48.88B
|
Composite
63.2
Moat
62.4
|
-
No YoY
|
10.6%
+2.0
YoY
|
|
|
HUM
Humana Inc.
|
43.30B
|
Composite
34.7
Moat
51.6
|
-
No YoY
|
1.1%
-0.9
YoY
|
|
43.05B
|
Composite
66.3
Moat
75.6
|
-
No YoY
|
31.6%
+2.7
YoY
|
|
|
38.77B
|
Composite
64.2
Moat
64.0
|
-
No YoY
|
13.7%
-0.5
YoY
|
|
|
HLN
Haleon plc
|
38.75B
|
Composite
65.9
Moat
70.1
|
-
No YoY
|
21.9%
+2.2
YoY
|
|
38.24B
|
Composite
77.0
Moat
75.2
|
3890.0
+3841.4
YoY
|
13.5%
+21.4
YoY
|
|
|
37.49B
|
Composite
70.8
Moat
65.2
|
-
No YoY
|
22.9%
+2.6
YoY
|
|
|
35.72B
|
Composite
64.0
Moat
69.6
|
-
No YoY
|
21.3%
-1.6
YoY
|
|
|
35.25B
|
Composite
47.0
Moat
45.2
|
27.08
-22.2
YoY
|
-42.1%
-34.8
YoY
|
|
|
35.18B
|
Composite
67.2
Moat
70.8
|
-
No YoY
|
28.2%
-0.1
YoY
|
|
|
NTRA
Natera, Inc.
|
32.77B
|
Composite
51.7
Moat
55.9
|
42.71
+17.7
YoY
|
-13.4%
-0.3
YoY
|
|
ALC
Alcon Inc.
|
31.85B
|
Composite
61.4
Moat
71.1
|
-
No YoY
|
13.1%
-1.2
YoY
|
|
ZTS
Zoetis Inc.
|
31.82B
|
Composite
74.6
Moat
84.1
|
-
No YoY
|
38.0%
+1.4
YoY
|
|
31.45B
|
Composite
27.6
Moat
39.7
|
-
No YoY
|
-3.9%
-5.9
YoY
|
|
|
RPRX
Royalty Pharma plc
|
30.85B
|
Composite
74.4
Moat
86.3
|
-
No YoY
|
65.6%
+8.5
YoY
|
|
ONC
BeiGene, Ltd.
|
30.21B
|
Composite
73.8
Moat
76.7
|
224.2
+191.3
YoY
|
8.4%
+23.3
YoY
|
|
BIIB
Biogen Inc.
|
29.02B
|
Composite
42.2
Moat
75.4
|
-
No YoY
|
25.0%
+1.4
YoY
|
|
28.01B
|
Composite
64.9
Moat
58.0
|
-
No YoY
|
14.0%
-0.7
YoY
|
|
|
27.58B
|
Composite
61.8
Moat
71.4
|
-
No YoY
|
13.4%
+0.0
YoY
|
|
|
RMD
ResMed Inc.
|
27.34B
|
Composite
69.2
Moat
80.3
|
-
No YoY
|
32.8%
+3.2
YoY
|
|
DXCM
DexCom, Inc.
|
26.65B
|
Composite
74.0
Moat
72.3
|
-
No YoY
|
19.6%
+4.7
YoY
|
|
25.98B
|
Composite
64.4
Moat
59.5
|
82.06
No YoY
|
8.0%
+5.1
YoY
|
|
|
VEEV
Veeva Systems Inc.
|
24.90B
|
Composite
68.7
Moat
83.2
|
-
No YoY
|
25.2%
+7.0
YoY
|
|
ILMN
Illumina, Inc.
|
24.42B
|
Composite
66.9
Moat
72.8
|
-
No YoY
|
18.8%
+5.1
YoY
|
|
MRNA
Moderna, Inc.
|
23.55B
|
Composite
49.0
Moat
51.9
|
28.06
-5.1
YoY
|
-1.6%
-0.3
YoY
|
|
23.52B
|
Composite
61.2
Moat
68.8
|
-
No YoY
|
27.8%
-1.3
YoY
|
|
|
23.29B
|
Composite
62.7
Moat
64.3
|
-
No YoY
|
20.1%
-0.3
YoY
|
|
|
22.85B
|
Composite
69.5
Moat
84.9
|
-
No YoY
|
47.7%
-2.7
YoY
|
|
|
BNTX
BioNTech SE
|
22.81B
|
Composite
51.9
Moat
64.7
|
-
No YoY
|
-22.3%
-0.7
YoY
|
|
22.61B
|
Composite
48.1
Moat
45.9
|
69.86
-32.0
YoY
|
-38.3%
-13.1
YoY
|
|
|
21.59B
|
Composite
67.8
Moat
57.0
|
-
No YoY
|
14.1%
+0.5
YoY
|
|
|
20.86B
|
Composite
63.8
Moat
55.0
|
-
No YoY
|
10.9%
+2.1
YoY
|
|
|
INSM
Insmed Incorporated
|
20.76B
|
Composite
53.8
Moat
54.7
|
25.16
+7.7
YoY
|
-1.9%
+0.2
YoY
|
|
20.03B
|
Composite
56.7
Moat
62.8
|
33.93
No YoY
|
-6.1%
+0.4
YoY
|
|
|
INCY
Incyte Corporation
|
19.62B
|
Composite
74.2
Moat
83.1
|
-
No YoY
|
26.1%
+23.7
YoY
|
|
19.56B
|
Composite
71.1
Moat
68.2
|
-
No YoY
|
17.6%
+0.8
YoY
|
|
|
VTRS
Viatris Inc.
|
17.91B
|
Composite
56.0
Moat
43.2
|
-
No YoY
|
-18.6%
-21.3
YoY
|
|
17.08B
|
Composite
39.4
Moat
59.5
|
42.02
-1.1
YoY
|
-44.4%
+15.6
YoY
|
|
|
HOLX
Hologic, Inc.
|
16.97B
|
Composite
63.4
Moat
60.6
|
-
No YoY
|
19.1%
-4.0
YoY
|
|
16.85B
|
Composite
68.9
Moat
72.0
|
-
No YoY
|
16.5%
-3.4
YoY
|
|
|
GMAB
Genmab A/S
|
16.45B
|
Composite
73.4
Moat
77.6
|
-
No YoY
|
33.6%
+1.1
YoY
|
|
16.25B
|
Composite
74.7
Moat
80.9
|
-
No YoY
|
22.2%
-2.5
YoY
|
|
|
15.40B
|
Composite
66.3
Moat
74.4
|
-
No YoY
|
16.5%
+2.3
YoY
|
|
|
14.17B
|
Composite
71.8
Moat
80.4
|
-
No YoY
|
12.1%
-5.7
YoY
|
|
|
ASND
Ascendis Pharma A/S
|
14.16B
|
Composite
61.1
Moat
65.3
|
21.93
+11.7
YoY
|
-18.9%
+57.7
YoY
|
|
14.01B
|
Composite
67.0
Moat
49.3
|
35.15
No YoY
|
2.3%
+0.5
YoY
|
|
|
13.50B
|
Composite
54.1
Moat
57.0
|
15.70
+5.8
YoY
|
-1.1%
+1.5
YoY
|
|
|
DVA
DaVita Inc.
|
13.35B
|
Composite
56.1
Moat
62.1
|
-
No YoY
|
14.7%
-0.5
YoY
|
|
13.01B
|
Composite
66.0
Moat
67.7
|
-
No YoY
|
21.1%
-0.1
YoY
|
|
|
EXEL
Exelixis, Inc.
|
12.91B
|
Composite
72.5
Moat
83.2
|
-
No YoY
|
38.5%
+6.7
YoY
|
|
12.90B
|
Composite
71.7
Moat
75.2
|
-
No YoY
|
13.9%
-0.9
YoY
|
|
|
12.76B
|
Composite
59.1
Moat
72.5
|
-
No YoY
|
16.7%
-1.4
YoY
|
|
|
12.75B
|
Composite
61.5
Moat
59.4
|
29.47
-2.5
YoY
|
-26.5%
+38.9
YoY
|
|
|
12.74B
|
Composite
60.0
Moat
56.8
|
-
No YoY
|
7.6%
-5.0
YoY
|
|
|
12.63B
|
Composite
56.1
Moat
63.2
|
-
No YoY
|
9.3%
+1.7
YoY
|
|
|
12.44B
|
Composite
59.6
Moat
68.0
|
-
No YoY
|
14.5%
-2.3
YoY
|
|
|
PEN
Penumbra, Inc.
|
12.44B
|
Composite
69.2
Moat
72.1
|
40.54
No YoY
|
13.5%
+6.3
YoY
|
|
12.25B
|
Composite
53.6
Moat
68.8
|
55.04
-35.9
YoY
|
-40.5%
+26.9
YoY
|
|
|
12.10B
|
Composite
60.5
Moat
54.2
|
-
No YoY
|
5.3%
-0.3
YoY
|
|
|
11.82B
|
Composite
63.5
Moat
60.8
|
24.40
+0.9
YoY
|
-31.3%
-28.5
YoY
|
|
|
11.52B
|
Composite
74.7
Moat
67.4
|
17.65
-13.8
YoY
|
11.9%
+181.1
YoY
|
|
|
11.09B
|
Composite
58.2
Moat
66.8
|
-
No YoY
|
22.1%
-1.3
YoY
|
|
|
11.08B
|
Composite
53.8
Moat
25.7
|
26.51
-8.3
YoY
|
-90.2%
-42.6
YoY
|
|
|
RVTY
Revvity, Inc.
|
11.05B
|
Composite
61.6
Moat
64.8
|
-
No YoY
|
12.5%
-0.1
YoY
|
|
10.80B
|
Composite
68.1
Moat
81.0
|
-
No YoY
|
16.6%
-0.1
YoY
|
|
|
ICLR
ICON plc
|
10.78B
|
Composite
56.6
Moat
57.1
|
-
No YoY
|
12.3%
-2.5
YoY
|
|
GMED
Globus Medical, Inc.
|
10.75B
|
Composite
72.0
Moat
71.5
|
-
No YoY
|
16.3%
+7.6
YoY
|
|
10.29B
|
Composite
29.5
Moat
49.9
|
185.2
No YoY
|
1.7%
-2.5
YoY
|
|
|
10.26B
|
Composite
76.4
Moat
80.6
|
71.91
+26.7
YoY
|
41.4%
+5.9
YoY
|
|
|
10.15B
|
Composite
43.8
Moat
49.7
|
-
No YoY
|
1.6%
-2.6
YoY
|
|
|
9.93B
|
Composite
54.1
Moat
74.8
|
38.52
+2.0
YoY
|
-
No YoY
|
|
|
9.85B
|
Composite
45.9
Moat
50.2
|
20.76
-11.9
YoY
|
-7.0%
+22.1
YoY
|
|
|
9.79B
|
Composite
61.9
Moat
72.8
|
-
No YoY
|
17.7%
+1.7
YoY
|
|
|
NUVL
Nuvalent, Inc.
|
9.75B
|
Composite
64.8
Moat
71.3
|
59.82
-12.7
YoY
|
-
No YoY
|
|
PODD
Insulet Corporation
|
9.63B
|
Composite
67.5
Moat
73.0
|
139.2
No YoY
|
17.5%
+2.6
YoY
|
|
MASI
Masimo Corporation
|
9.42B
|
Composite
57.2
Moat
58.5
|
-
No YoY
|
20.3%
+18.5
YoY
|
|
9.16B
|
Composite
55.8
Moat
64.8
|
-
No YoY
|
8.4%
0.0
YoY
|
|
|
HSIC
Henry Schein, Inc.
|
8.96B
|
Composite
62.9
Moat
60.1
|
-
No YoY
|
5.8%
-0.0
YoY
|
|
8.91B
|
Composite
53.7
Moat
56.7
|
-
No YoY
|
12.7%
+1.7
YoY
|
|
|
8.71B
|
Composite
58.8
Moat
29.5
|
53.64
+7.7
YoY
|
-145.1%
-108.7
YoY
|
|
|
TECH
Bio-Techne Corp
|
8.71B
|
Composite
71.9
Moat
78.0
|
-
No YoY
|
19.9%
-1.4
YoY
|
|
8.63B
|
Composite
61.5
Moat
65.1
|
-
No YoY
|
11.5%
+0.8
YoY
|
|
|
BRKR
Bruker Corporation
|
8.61B
|
Composite
64.0
Moat
54.1
|
-
No YoY
|
6.3%
-5.0
YoY
|
|
TEM
Tempus AI, Inc.
|
8.59B
|
Composite
49.4
Moat
35.0
|
28.45
+17.4
YoY
|
-19.9%
+79.8
YoY
|
|
8.56B
|
Composite
70.9
Moat
81.5
|
-
No YoY
|
5.9%
-14.4
YoY
|
|
|
OSCR
Oscar Health, Inc.
|
8.55B
|
Composite
37.6
Moat
40.9
|
112.9
No YoY
|
-3.4%
-4.0
YoY
|
|
8.33B
|
Composite
67.8
Moat
67.8
|
68.77
-23.3
YoY
|
20.0%
+7.3
YoY
|
|
|
8.18B
|
Composite
69.6
Moat
79.5
|
-
No YoY
|
58.5%
+4.1
YoY
|
|
|
8.18B
|
Composite
51.2
Moat
55.1
|
30.15
-13.6
YoY
|
-8.9%
-3.5
YoY
|
|
|
7.87B
|
Composite
46.4
Moat
31.6
|
28.88
-6.9
YoY
|
-23.4%
+28.2
YoY
|
|
|
ABVX
Abivax SA
|
7.83B
|
Composite
47.3
Moat
41.3
|
39.50
+28.3
YoY
|
-
No YoY
|
|
GKOS
Glaukos Corporation
|
7.71B
|
Composite
48.2
Moat
46.7
|
226.2
+163.8
YoY
|
-39.3%
-11.1
YoY
|
|
ATR
AptarGroup, Inc.
|
7.66B
|
Composite
62.6
Moat
64.8
|
-
No YoY
|
13.5%
-0.7
YoY
|
|
IBRX
ImmunityBio, Inc.
|
7.56B
|
Composite
52.3
Moat
61.1
|
4.59
-4.1
YoY
|
-2.3%
+21.1
YoY
|
|
PCVX
Vaxcyte, Inc.
|
7.52B
|
Composite
51.6
Moat
52.6
|
28.57
-17.7
YoY
|
-
No YoY
|
|
7.52B
|
Composite
60.3
Moat
67.6
|
-
No YoY
|
8.5%
-2.0
YoY
|
|
|
QGEN
Qiagen N.V.
|
7.50B
|
Composite
62.6
Moat
67.5
|
-
No YoY
|
24.9%
+14.8
YoY
|
|
ALKS
Alkermes plc
|
7.50B
|
Composite
65.0
Moat
67.4
|
-
No YoY
|
17.2%
-9.8
YoY
|
|
MTSR
Metsera, Inc.
|
7.43B
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
7.40B
|
Composite
68.7
Moat
64.6
|
58.37
+32.0
YoY
|
-3.4%
-61.6
YoY
|
|
|
IMVT
Immunovant, Inc.
|
7.26B
|
Composite
55.3
Moat
63.4
|
22.79
-12.8
YoY
|
-
No YoY
|
|
7.16B
|
Composite
62.0
Moat
67.6
|
-
No YoY
|
8.5%
-2.0
YoY
|
|
|
RGEN
Repligen Corporation
|
7.14B
|
Composite
61.5
Moat
54.9
|
-
No YoY
|
8.1%
+13.1
YoY
|
|
7.07B
|
Composite
71.9
Moat
69.7
|
-
No YoY
|
16.9%
+4.1
YoY
|
|
|
6.95B
|
Composite
55.2
Moat
53.7
|
33.78
+9.5
YoY
|
-1.0%
+1.0
YoY
|
|
|
6.91B
|
Composite
67.2
Moat
67.4
|
-
No YoY
|
20.5%
-8.8
YoY
|
|
|
ACLX
Arcellx, Inc.
|
6.75B
|
Composite
55.0
Moat
45.8
|
25.70
-58.7
YoY
|
-11.4%
-10.1
YoY
|
|
6.72B
|
Composite
61.4
Moat
75.6
|
127.0
+60.6
YoY
|
49.5%
+67.7
YoY
|
|
|
LQDA
Liquidia Corporation
|
6.71B
|
Composite
62.8
Moat
40.7
|
64.12
+41.5
YoY
|
-32.5%
-23.8
YoY
|
|
AVTR
Avantor, Inc.
|
6.54B
|
Composite
54.3
Moat
55.2
|
-
No YoY
|
8.3%
-1.1
YoY
|
|
6.53B
|
Composite
52.5
Moat
70.6
|
48.43
+33.3
YoY
|
-4.2%
+21.8
YoY
|
|
|
6.22B
|
Composite
54.5
Moat
53.4
|
18.24
-22.5
YoY
|
-13.8%
+11.1
YoY
|
|
|
6.13B
|
Composite
54.7
Moat
43.8
|
40.88
+24.3
YoY
|
-
No YoY
|
|
|
6.11B
|
Composite
56.1
Moat
71.0
|
148.8
+87.4
YoY
|
-49.9%
No YoY
|
|
|
PACS
PACS Group, Inc.
|
5.98B
|
Composite
52.1
Moat
48.2
|
-
No YoY
|
5.9%
+2.8
YoY
|
|
5.89B
|
Composite
52.4
Moat
55.2
|
14.70
-11.4
YoY
|
-4.0%
+2.9
YoY
|
|
|
CGON
CG Oncology, Inc.
|
5.84B
|
Composite
54.7
Moat
39.2
|
113.1
+63.8
YoY
|
-47.2%
+53.5
YoY
|
|
CHE
Chemed Corp
|
5.79B
|
Composite
62.4
Moat
74.0
|
-
No YoY
|
13.4%
-1.7
YoY
|
|
BLTE
Belite Bio, Inc
|
5.79B
|
Composite
55.5
Moat
51.6
|
159.8
+100.2
YoY
|
-
No YoY
|
|
5.51B
|
Composite
74.0
Moat
83.3
|
-
No YoY
|
17.6%
+3.8
YoY
|
|
|
5.45B
|
Composite
59.1
Moat
68.0
|
113.6
+20.1
YoY
|
-13.3%
+35.1
YoY
|
|
|
5.39B
|
Composite
41.7
Moat
60.7
|
-
No YoY
|
2.9%
-15.0
YoY
|
|
|
5.32B
|
Composite
55.8
Moat
62.6
|
233.6
No YoY
|
3.1%
-1.2
YoY
|
|
|
5.30B
|
Composite
43.0
Moat
47.7
|
58.56
+6.8
YoY
|
-36.2%
+20.0
YoY
|
|
|
5.30B
|
Composite
51.3
Moat
53.3
|
23.60
-17.9
YoY
|
-49.7%
-36.1
YoY
|
|
|
5.25B
|
Composite
65.2
Moat
71.2
|
56.17
+49.1
YoY
|
5.5%
+26.6
YoY
|
|
|
5.24B
|
Composite
55.1
Moat
44.3
|
68.72
-91.3
YoY
|
-13.3%
+46.8
YoY
|
|
|
5.21B
|
Composite
44.8
Moat
32.4
|
23.87
-4.1
YoY
|
-
No YoY
|
|
|
5.17B
|
Composite
56.5
Moat
58.3
|
-
No YoY
|
13.2%
+0.7
YoY
|
|
|
ORKA
ARCA biopharma Inc
|
5.15B
|
Composite
54.5
Moat
59.3
|
45.85
-32.1
YoY
|
-
No YoY
|
|
5.12B
|
Composite
68.2
Moat
67.5
|
18.73
-5.6
YoY
|
-12.8%
-11.4
YoY
|
|
|
GRFS
Grifols, S.A.
|
5.01B
|
Composite
40.0
Moat
63.0
|
4879.4
No YoY
|
16.6%
+0.6
YoY
|
|
4.78B
|
Composite
50.2
Moat
41.3
|
37.59
-4.7
YoY
|
-87.4%
-71.1
YoY
|
|
|
ERAS
Erasca, Inc.
|
4.69B
|
Composite
56.2
Moat
68.0
|
34.71
+2.0
YoY
|
-
No YoY
|
|
4.62B
|
Composite
58.8
Moat
56.4
|
-
No YoY
|
16.8%
+2.2
YoY
|
|
|
4.55B
|
Composite
68.1
Moat
73.7
|
88.50
+38.8
YoY
|
5.4%
-1.0
YoY
|
|
|
4.49B
|
Composite
65.5
Moat
74.6
|
24.08
No YoY
|
31.1%
+4.1
YoY
|
|
|
4.40B
|
Composite
47.6
Moat
43.1
|
64.64
-43.5
YoY
|
0.4%
+4.1
YoY
|
|
|
4.40B
|
Composite
71.1
Moat
59.3
|
17.31
No YoY
|
11.4%
+22.2
YoY
|
|
|
CELC
Celcuity Inc.
|
4.39B
|
Composite
46.3
Moat
55.4
|
34.56
+0.8
YoY
|
-
No YoY
|
|
RDNT
RadNet, Inc.
|
4.38B
|
Composite
61.2
Moat
55.2
|
-
No YoY
|
4.1%
-2.0
YoY
|
|
LIVN
LivaNova PLC
|
4.32B
|
Composite
58.9
Moat
71.3
|
-
No YoY
|
14.4%
+4.1
YoY
|
|
VCYT
Veracyte, Inc.
|
4.24B
|
Composite
64.0
Moat
73.1
|
67.23
No YoY
|
14.3%
+9.8
YoY
|
|
4.18B
|
Composite
61.1
Moat
48.8
|
306.9
+153.4
YoY
|
-17.2%
+14.6
YoY
|
|
|
4.15B
|
Composite
57.2
Moat
62.7
|
-
No YoY
|
8.7%
+3.2
YoY
|
|
|
4.12B
|
Composite
58.0
Moat
65.4
|
29.65
+6.1
YoY
|
-1.8%
+1.7
YoY
|
|
|
4.01B
|
Composite
62.2
Moat
68.0
|
-
No YoY
|
12.2%
+0.7
YoY
|
|
|
3.96B
|
Composite
52.7
Moat
67.5
|
44.23
-7.5
YoY
|
-
No YoY
|
|
|
3.84B
|
Composite
71.7
Moat
83.9
|
-
No YoY
|
43.8%
+4.1
YoY
|
|
|
INDV
Indivior PLC
|
3.81B
|
Composite
55.9
Moat
57.0
|
16.40
-2662.6
YoY
|
21.1%
+2.0
YoY
|
|
3.78B
|
Composite
70.9
Moat
78.2
|
43.86
-5.9
YoY
|
9.8%
+1.0
YoY
|
|
|
3.78B
|
Composite
48.0
Moat
33.6
|
71.91
+31.6
YoY
|
-95.3%
+230.8
YoY
|
|
|
3.77B
|
Composite
54.0
Moat
50.3
|
28.26
-9.4
YoY
|
-19.7%
+18.8
YoY
|
|
|
3.76B
|
Composite
45.2
Moat
47.2
|
30.39
-93.0
YoY
|
-5203.4%
No YoY
|
|
|
3.70B
|
Composite
56.8
Moat
67.3
|
25.24
-3.5
YoY
|
-59.5%
-56.4
YoY
|
|
|
DOCS
Doximity, Inc.
|
3.67B
|
Composite
68.2
Moat
84.3
|
-
No YoY
|
40.3%
+4.2
YoY
|
|
3.65B
|
Composite
51.8
Moat
70.5
|
-
No YoY
|
96.5%
+80.5
YoY
|
|
|
3.60B
|
Composite
49.6
Moat
49.9
|
63.13
+34.2
YoY
|
-10.0%
-6.2
YoY
|
|
|
3.57B
|
Composite
54.6
Moat
47.6
|
56.02
No YoY
|
1.7%
+4.2
YoY
|
|
|
3.54B
|
Composite
65.8
Moat
57.5
|
29.40
-66.3
YoY
|
-2.7%
+3.8
YoY
|
|
|
OGN
Organon & Co.
|
3.52B
|
Composite
27.6
Moat
62.5
|
-
No YoY
|
20.7%
-2.5
YoY
|
|
3.45B
|
Composite
53.0
Moat
52.8
|
33.05
+6.7
YoY
|
-
No YoY
|
|
|
3.44B
|
Composite
66.9
Moat
62.3
|
32.04
-79.1
YoY
|
-4.9%
+14.5
YoY
|
|
|
3.42B
|
Composite
54.7
Moat
56.4
|
69.04
+39.3
YoY
|
-1.6%
-0.4
YoY
|
|
|
ICUI
ICU Medical, Inc.
|
3.40B
|
Composite
55.4
Moat
53.2
|
41.14
No YoY
|
4.8%
+0.7
YoY
|
|
3.38B
|
Composite
68.3
Moat
64.8
|
14.85
+11.6
YoY
|
2.2%
-8.2
YoY
|
|
|
3.37B
|
Composite
65.0
Moat
66.7
|
-
No YoY
|
14.8%
+1.5
YoY
|
|
|
3.34B
|
Composite
55.6
Moat
61.7
|
-
No YoY
|
6.0%
-0.5
YoY
|
|
|
3.34B
|
Composite
33.6
Moat
41.7
|
67.13
No YoY
|
0.5%
-1.2
YoY
|
|
|
3.33B
|
Composite
69.2
Moat
66.4
|
24.39
+11.2
YoY
|
-3.2%
+62.1
YoY
|
|
|
3.32B
|
Composite
69.5
Moat
75.4
|
-
No YoY
|
24.2%
+11.1
YoY
|
|
|
WRBY
Warby Parker Inc.
|
3.31B
|
Composite
59.9
Moat
55.1
|
96.17
No YoY
|
-0.6%
+3.3
YoY
|
|
3.23B
|
Composite
57.3
Moat
68.6
|
78.10
-12.8
YoY
|
-
No YoY
|
|
|
3.15B
|
Composite
58.9
Moat
69.2
|
-
No YoY
|
8.5%
+1.5
YoY
|
|
|
3.06B
|
Composite
62.5
Moat
61.8
|
-
No YoY
|
12.9%
+0.1
YoY
|
|
|
3.01B
|
Composite
63.8
Moat
62.7
|
32.78
-21.9
YoY
|
-72.8%
-26.1
YoY
|
|
|
ALMS
Alumis Inc.
|
2.98B
|
Composite
46.0
Moat
32.6
|
10.02
-3.5
YoY
|
-18.9%
No YoY
|
|
2.96B
|
Composite
64.0
Moat
48.0
|
-
No YoY
|
1.6%
+0.6
YoY
|
|
|
QURE
uniQure N.V.
|
2.92B
|
Composite
51.6
Moat
42.7
|
41.98
+17.8
YoY
|
-11.7%
-4.9
YoY
|
|
2.80B
|
Composite
53.0
Moat
59.4
|
78.97
+27.6
YoY
|
-
No YoY
|
|
|
2.78B
|
Composite
65.3
Moat
69.2
|
28.02
+1.4
YoY
|
-20.6%
+66.2
YoY
|
|
|
2.76B
|
Composite
74.2
Moat
77.8
|
50.61
-31.0
YoY
|
7.8%
No YoY
|
|
|
2.76B
|
Composite
53.3
Moat
48.3
|
35.57
-21.5
YoY
|
-
No YoY
|
|
|
2.73B
|
Composite
69.8
Moat
66.8
|
42.11
+18.9
YoY
|
-15.7%
+50.2
YoY
|
|
|
2.71B
|
Composite
34.9
Moat
27.4
|
21.56
+2.0
YoY
|
-4.4%
-1.1
YoY
|
|
|
IRON
Disc Medicine, Inc.
|
2.70B
|
Composite
55.7
Moat
56.0
|
52.63
-10.0
YoY
|
-
No YoY
|
|
2.70B
|
Composite
53.8
Moat
58.8
|
17.67
+3.1
YoY
|
-79.5%
+16.2
YoY
|
|
|
2.69B
|
Composite
59.1
Moat
58.2
|
-
No YoY
|
5.0%
+10.1
YoY
|
|
|
GRAL
GRAIL, Inc.
|
2.67B
|
Composite
36.9
Moat
38.3
|
36.30
+20.4
YoY
|
-3.6%
+2.5
YoY
|
|
2.61B
|
Composite
72.8
Moat
67.5
|
363.7
+311.0
YoY
|
17.9%
+9.4
YoY
|
|
|
2.58B
|
Composite
64.5
Moat
63.0
|
-
No YoY
|
-5.1%
-16.6
YoY
|
|
|
2.55B
|
Composite
47.0
Moat
29.1
|
29.50
-25.7
YoY
|
-186.0%
-158.2
YoY
|
|
|
2.53B
|
Composite
49.9
Moat
58.4
|
18.53
+13.1
YoY
|
-18.5%
+11.6
YoY
|
|
|
2.44B
|
Composite
49.0
Moat
49.4
|
53.67
+19.9
YoY
|
-
No YoY
|
|
|
AXGN
AxoGen, Inc.
|
2.39B
|
Composite
63.4
Moat
62.9
|
65.13
+28.7
YoY
|
-3.5%
-1.7
YoY
|
|
BHVN
Biohaven Ltd.
|
2.33B
|
Composite
47.9
Moat
19.9
|
6.28
-3.7
YoY
|
-
No YoY
|
|
2.32B
|
Composite
70.0
Moat
70.0
|
74.01
+25.0
YoY
|
39.0%
+39.5
YoY
|
|
|
2.32B
|
Composite
32.6
Moat
50.7
|
-
No YoY
|
11.7%
-4.8
YoY
|
|
|
PHVS
Pharvaris N.V.
|
2.31B
|
Composite
47.6
Moat
52.5
|
25.53
-2.5
YoY
|
-
No YoY
|
|
2.29B
|
Composite
40.8
Moat
28.3
|
18.52
+1.3
YoY
|
-
No YoY
|
|
|
2.25B
|
Composite
72.8
Moat
78.1
|
125.7
+66.9
YoY
|
37.1%
+29.2
YoY
|
|
|
2.22B
|
Composite
62.0
Moat
65.8
|
51.02
-30.7
YoY
|
-80.8%
-79.1
YoY
|
|
|
NKTR
Nektar Therapeutics
|
2.22B
|
Composite
47.6
Moat
61.3
|
14.14
-3.3
YoY
|
-2.4%
-1.0
YoY
|
|
ASTH
Astrana Health Inc.
|
2.21B
|
Composite
50.6
Moat
43.4
|
-
No YoY
|
2.5%
-1.9
YoY
|
|
2.19B
|
Composite
54.1
Moat
51.1
|
13.68
-7.0
YoY
|
-6.5%
+2.7
YoY
|
|
|
IMNM
Immunome, Inc.
|
2.17B
|
Composite
55.0
Moat
41.2
|
41.07
+17.5
YoY
|
-32.3%
-15.3
YoY
|
|
2.15B
|
Composite
63.0
Moat
75.8
|
-
No YoY
|
30.7%
+0.3
YoY
|
|
|
2.09B
|
Composite
58.8
Moat
45.5
|
55.33
+41.0
YoY
|
-
No YoY
|
|
|
2.09B
|
Composite
60.1
Moat
52.7
|
56.09
-1.4
YoY
|
-
No YoY
|
|
|
2.09B
|
Composite
51.7
Moat
55.0
|
27.49
-0.0
YoY
|
-8.7%
+2.9
YoY
|
|
|
2.06B
|
Composite
56.3
Moat
52.7
|
43.17
+8.2
YoY
|
-5.2%
-2.5
YoY
|
|
|
2.05B
|
Composite
47.8
Moat
49.0
|
-
No YoY
|
6.1%
+1.0
YoY
|
|
|
VCEL
Vericel Corporation
|
2.05B
|
Composite
73.5
Moat
78.0
|
-
No YoY
|
4.0%
+2.1
YoY
|
|
PGNY
Progyny, Inc.
|
2.04B
|
Composite
66.0
Moat
65.6
|
-
No YoY
|
6.6%
+0.8
YoY
|
|
ZLAB
Zai Lab Limited
|
2.04B
|
Composite
57.9
Moat
64.1
|
43.54
-5.3
YoY
|
-49.9%
+18.8
YoY
|
|
XRAY
DENTSPLY SIRONA Inc.
|
2.03B
|
Composite
49.6
Moat
53.2
|
-
No YoY
|
6.9%
+1.9
YoY
|
|
2.02B
|
Composite
68.0
Moat
78.5
|
-
No YoY
|
27.2%
+3.4
YoY
|
|
|
NUVB
Nuvation Bio Inc.
|
2.01B
|
Composite
59.5
Moat
24.3
|
36.62
-9.6
YoY
|
-3.4%
+71.9
YoY
|
|
MESO
Mesoblast Limited
|
2.00B
|
Composite
55.7
Moat
57.3
|
38.71
+23.2
YoY
|
-3.6%
+6.2
YoY
|
|
ADMA
ADMA Biologics Inc
|
1.99B
|
Composite
65.0
Moat
77.6
|
17.45
+12.0
YoY
|
37.5%
+4.9
YoY
|
|
NEOG
Neogen Corporation
|
1.94B
|
Composite
53.8
Moat
49.6
|
-
No YoY
|
-0.2%
-6.5
YoY
|
|
1.94B
|
Composite
72.5
Moat
80.6
|
-
No YoY
|
24.0%
-2.7
YoY
|
|
|
1.93B
|
Composite
59.5
Moat
66.2
|
-
No YoY
|
12.1%
+2.9
YoY
|
|
|
1.93B
|
Composite
68.9
Moat
65.0
|
29.97
+0.2
YoY
|
-11.2%
-8.4
YoY
|
|
|
1.90B
|
Composite
50.1
Moat
63.9
|
-
No YoY
|
14.2%
-0.4
YoY
|
|
|
1.90B
|
Composite
49.2
Moat
45.6
|
142.2
+116.7
YoY
|
-88.5%
+2.2
YoY
|
|
|
1.89B
|
Composite
22.3
Moat
25.8
|
83.07
+45.6
YoY
|
-7.1%
-2.3
YoY
|
|
|
1.88B
|
Composite
54.0
Moat
39.4
|
41.22
+20.7
YoY
|
-11.3%
-0.9
YoY
|
|
|
GLPG
Galapagos NV
|
1.87B
|
Composite
65.1
Moat
79.9
|
116.9
+8.0
YoY
|
40.6%
+108.9
YoY
|
|
1.86B
|
Composite
56.0
Moat
64.8
|
54.88
-24.1
YoY
|
-29.9%
-41.4
YoY
|
|
|
1.83B
|
Composite
66.8
Moat
60.6
|
18.55
No YoY
|
12.6%
+12.2
YoY
|
|
|
1.83B
|
Composite
56.1
Moat
56.8
|
67.29
+10.8
YoY
|
-
No YoY
|
|
|
1.82B
|
Composite
52.4
Moat
48.7
|
37.97
+0.9
YoY
|
-5.1%
+985.1
YoY
|
|
|
1.81B
|
Composite
50.5
Moat
56.2
|
28.52
-13.9
YoY
|
-3.4%
+0.5
YoY
|
|
|
1.81B
|
Composite
59.5
Moat
51.5
|
11.78
+0.8
YoY
|
-1.5%
+0.9
YoY
|
|
|
1.81B
|
Composite
54.5
Moat
49.0
|
30.84
+18.2
YoY
|
-2.9%
-13.1
YoY
|
|
|
1.80B
|
Composite
68.0
Moat
62.2
|
-
No YoY
|
15.3%
-1.4
YoY
|
|
|
1.79B
|
Composite
59.1
Moat
38.5
|
33.29
+13.6
YoY
|
-56.2%
-38.0
YoY
|
|
|
1.79B
|
Composite
48.3
Moat
59.7
|
32.29
-26.4
YoY
|
-
No YoY
|
|
|
1.78B
|
Composite
30.6
Moat
12.4
|
17.90
-21.1
YoY
|
-219.8%
-136.9
YoY
|
|
|
1.77B
|
Composite
60.9
Moat
66.6
|
-
No YoY
|
9.7%
+0.8
YoY
|
|
|
NBTX
Nanobiotix S.A.
|
1.76B
|
Composite
49.1
Moat
77.9
|
18.94
-11.6
YoY
|
-36.5%
-42.4
YoY
|
|
OMCL
Omnicell, Inc.
|
1.76B
|
Composite
55.7
Moat
52.2
|
-
No YoY
|
0.4%
+0.4
YoY
|
|
1.75B
|
Composite
52.6
Moat
54.9
|
42.70
+9.2
YoY
|
-
No YoY
|
|
|
1.75B
|
Composite
57.4
Moat
62.3
|
48.79
No YoY
|
-2.7%
+8.2
YoY
|
|
|
1.75B
|
Composite
50.5
Moat
52.5
|
41.51
+22.9
YoY
|
-
No YoY
|
|
|
ANAB
AnaptysBio, Inc.
|
1.75B
|
Composite
65.6
Moat
70.2
|
34.17
-4.7
YoY
|
20.4%
+21.7
YoY
|
|
1.74B
|
Composite
57.1
Moat
62.3
|
9.30
No YoY
|
20.1%
+0.8
YoY
|
|
|
1.74B
|
Composite
55.6
Moat
47.0
|
253.8
+225.6
YoY
|
-6.5%
-0.1
YoY
|
|
|
1.73B
|
Composite
30.9
Moat
41.1
|
114.4
+35.7
YoY
|
-3.5%
+1.3
YoY
|
|
|
1.72B
|
Composite
59.4
Moat
53.2
|
4.76
-27.5
YoY
|
10.7%
+3.7
YoY
|
|
|
PGEN
Precigen, Inc.
|
1.72B
|
Composite
39.1
Moat
35.2
|
13.37
-3.9
YoY
|
-11.0%
+13.1
YoY
|
|
1.71B
|
Composite
54.8
Moat
53.3
|
15.37
-10.1
YoY
|
-1.6%
+12.8
YoY
|
|
|
URGN
UroGen Pharma Ltd.
|
1.70B
|
Composite
47.4
Moat
60.0
|
8.90
-20.5
YoY
|
-1.1%
-0.1
YoY
|
|
1.70B
|
Composite
48.2
Moat
54.7
|
27.82
-64.7
YoY
|
-1.6%
No YoY
|
|
|
1.70B
|
Composite
26.0
Moat
27.6
|
11.42
-5.2
YoY
|
-
No YoY
|
|
|
1.70B
|
Composite
57.7
Moat
51.2
|
54.68
+9.2
YoY
|
-1.9%
+93.7
YoY
|
|
|
ZYME
Zymeworks Inc.
|
1.70B
|
Composite
56.5
Moat
61.1
|
83.19
+58.6
YoY
|
-87.3%
-85.8
YoY
|
|
1.69B
|
Composite
53.1
Moat
44.5
|
19.86
+3.5
YoY
|
-8.7%
-0.5
YoY
|
|
|
INVA
Innoviva, Inc.
|
1.66B
|
Composite
74.4
Moat
81.0
|
-
No YoY
|
39.8%
-6.7
YoY
|
|
NVCR
NovoCure Limited
|
1.65B
|
Composite
53.4
Moat
56.4
|
109.6
-327.3
YoY
|
-23.5%
+4.7
YoY
|
|
1.65B
|
Composite
61.6
Moat
58.3
|
59.45
+50.8
YoY
|
-2.8%
+4.8
YoY
|
|
|
1.63B
|
Composite
48.6
Moat
47.2
|
24.12
-22.0
YoY
|
-
No YoY
|
|
|
1.61B
|
Composite
46.3
Moat
46.5
|
14.30
-10.0
YoY
|
-7.2%
+1.5
YoY
|
|
|
1.61B
|
Composite
49.9
Moat
53.2
|
46.59
-32.0
YoY
|
-
No YoY
|
|
|
HROW
Harrow, Inc.
|
1.58B
|
Composite
66.5
Moat
60.5
|
25.54
No YoY
|
11.2%
+6.7
YoY
|
|
1.58B
|
Composite
58.8
Moat
67.8
|
198.5
+134.8
YoY
|
-43.8%
-42.8
YoY
|
|
|
ARDX
Ardelyx, Inc.
|
1.57B
|
Composite
64.5
Moat
69.0
|
66.98
+42.3
YoY
|
-10.1%
-1.7
YoY
|
|
SEPN
Septerna, Inc.
|
1.57B
|
Composite
67.8
Moat
42.7
|
62.41
+35.0
YoY
|
-1.8%
+73.4
YoY
|
|
1.55B
|
Composite
53.5
Moat
63.3
|
178.5
No YoY
|
3.0%
-0.1
YoY
|
|
|
1.52B
|
Composite
65.3
Moat
47.1
|
37.41
+5.1
YoY
|
-
No YoY
|
|
|
GHRS
GH Research PLC
|
1.52B
|
Composite
51.4
Moat
60.8
|
77.34
+35.0
YoY
|
-
No YoY
|
|
1.50B
|
Composite
57.9
Moat
25.6
|
30.35
+25.6
YoY
|
-31.9%
-29.4
YoY
|
|
|
1.49B
|
Composite
41.9
Moat
39.4
|
29.92
+20.9
YoY
|
-27.7%
+304.0
YoY
|
|
|
GLTO
Galecto, Inc.
|
1.49B
|
Composite
56.0
Moat
43.4
|
9.13
-1.6
YoY
|
-
No YoY
|
|
NVAX
Novavax, Inc.
|
1.48B
|
Composite
56.3
Moat
69.5
|
126.9
+117.4
YoY
|
40.3%
+76.8
YoY
|
|
1.48B
|
Composite
72.9
Moat
69.2
|
1.56
+0.7
YoY
|
20.8%
+17.1
YoY
|
|
|
ATRC
AtriCure, Inc.
|
1.46B
|
Composite
59.1
Moat
71.1
|
65.64
-38.1
YoY
|
-0.6%
+8.0
YoY
|
|
1.46B
|
Composite
51.8
Moat
52.7
|
2551.2
+2471.5
YoY
|
-9.1%
+3.8
YoY
|
|
|
TDOC
Teladoc Health, Inc.
|
1.46B
|
Composite
59.1
Moat
47.5
|
-
No YoY
|
-10.4%
-2.3
YoY
|
|
1.45B
|
Composite
56.2
Moat
71.9
|
98.15
+71.2
YoY
|
-11.3%
+11.4
YoY
|
|
|
1.45B
|
Composite
38.1
Moat
56.4
|
65.74
No YoY
|
-19.2%
-15.2
YoY
|
|
|
1.45B
|
Composite
63.1
Moat
62.3
|
-
No YoY
|
-32.0%
-27.9
YoY
|
|
|
1.44B
|
Composite
50.4
Moat
48.4
|
17.31
-11.0
YoY
|
-4.6%
No YoY
|
|
|
1.42B
|
Composite
58.3
Moat
75.7
|
36.65
+32.6
YoY
|
34.4%
No YoY
|
|
|
1.37B
|
Composite
49.9
Moat
47.0
|
-
No YoY
|
1.1%
-0.7
YoY
|
|
|
1.37B
|
Composite
39.6
Moat
21.0
|
11.48
+2.1
YoY
|
-103.9%
+1553.4
YoY
|
|
|
1.36B
|
Composite
58.1
Moat
60.2
|
45.21
No YoY
|
-69.2%
-41.2
YoY
|
|
|
IMTX
Immatics N.V.
|
1.34B
|
Composite
51.5
Moat
65.8
|
31.89
-14.0
YoY
|
-3.8%
+21.0
YoY
|
|
PRGO
Perrigo Company plc
|
1.33B
|
Composite
45.1
Moat
39.8
|
-
No YoY
|
-26.4%
-33.5
YoY
|
|
1.31B
|
Composite
56.5
Moat
55.3
|
37.31
+3.5
YoY
|
-10.8%
+9.4
YoY
|
|
|
1.31B
|
Composite
45.9
Moat
40.7
|
23.90
-11.3
YoY
|
-21.1%
+11.6
YoY
|
|
|
1.29B
|
Composite
52.0
Moat
62.0
|
142.7
No YoY
|
5.1%
-1.7
YoY
|
|
|
CDNA
CareDx, Inc.
|
1.29B
|
Composite
56.4
Moat
64.2
|
153.6
+14.3
YoY
|
-6.6%
+9.5
YoY
|
|
AHCO
AdaptHealth Corp.
|
1.28B
|
Composite
63.2
Moat
59.1
|
-
No YoY
|
5.7%
-2.8
YoY
|
|
1.27B
|
Composite
61.1
Moat
60.3
|
42.42
-46.2
YoY
|
-17.3%
-8.6
YoY
|
|
|
1.26B
|
Composite
63.9
Moat
58.8
|
-
No YoY
|
8.5%
+3.3
YoY
|
|
|
ALVO
Alvotech
|
1.22B
|
Composite
49.3
Moat
49.0
|
41.20
+38.6
YoY
|
13.3%
-0.9
YoY
|
|
1.22B
|
Composite
52.9
Moat
37.3
|
33.43
No YoY
|
-1.9%
+1.1
YoY
|
|
|
MNKD
MannKind Corporation
|
1.20B
|
Composite
64.7
Moat
70.1
|
25.41
-14.3
YoY
|
11.1%
-12.9
YoY
|
|
1.20B
|
Composite
54.6
Moat
51.8
|
40.36
+11.8
YoY
|
-33.7%
+9.3
YoY
|
|
|
1.19B
|
Composite
74.5
Moat
75.7
|
-
No YoY
|
5.6%
+1.1
YoY
|
|
|
1.19B
|
Composite
69.9
Moat
64.2
|
23.24
+4.8
YoY
|
8.5%
+25.1
YoY
|
|
|
1.19B
|
Composite
57.8
Moat
49.4
|
38.53
+14.5
YoY
|
-5.0%
-4.0
YoY
|
|
|
1.18B
|
Composite
47.7
Moat
38.9
|
-
No YoY
|
1.2%
-2.8
YoY
|
|
|
IRMD
iRadimed Corporation
|
1.17B
|
Composite
74.2
Moat
82.5
|
-
No YoY
|
31.2%
+1.2
YoY
|
|
1.17B
|
Composite
56.5
Moat
55.9
|
3.42
No YoY
|
5.4%
+0.0
YoY
|
|
|
SVRA
Savara, Inc.
|
1.17B
|
Composite
53.7
Moat
49.2
|
27.99
+1.5
YoY
|
-
No YoY
|
|
AVNS
Avanos Medical, Inc.
|
1.17B
|
Composite
59.1
Moat
53.0
|
-
No YoY
|
-8.8%
-14.7
YoY
|
|
ABSI
Absci Corporation
|
1.16B
|
Composite
43.9
Moat
34.3
|
18.63
-0.0
YoY
|
-44.8%
-20.8
YoY
|
|
1.15B
|
Composite
47.6
Moat
48.3
|
15.30
-20.0
YoY
|
-7.8%
-4.4
YoY
|
|
|
1.15B
|
Composite
38.1
Moat
32.4
|
29.23
+3.6
YoY
|
-26.6%
-23.0
YoY
|
|
|
SDGR
Schrodinger, Inc.
|
1.14B
|
Composite
50.4
Moat
37.2
|
26.85
-13.8
YoY
|
-65.2%
-64.2
YoY
|
|
1.08B
|
Composite
66.5
Moat
68.4
|
-
No YoY
|
22.9%
-3.6
YoY
|
|
|
1.08B
|
Composite
39.0
Moat
45.5
|
28.25
-12.6
YoY
|
-19.3%
+19.0
YoY
|
|
|
PSNL
Personalis, Inc.
|
1.07B
|
Composite
37.2
Moat
29.1
|
38.42
-10.8
YoY
|
-1.3%
+79.4
YoY
|
|
1.06B
|
Composite
51.5
Moat
65.4
|
25.80
-7.1
YoY
|
-3.6%
No YoY
|
|
|
1.06B
|
Composite
46.9
Moat
54.4
|
17.07
+5.2
YoY
|
-1.3%
+3.6
YoY
|
|
|
CVAC
CureVac N.V.
|
1.05B
|
Composite
69.9
Moat
72.8
|
18.15
-2.8
YoY
|
33.2%
+38.3
YoY
|
|
XNCR
Xencor, Inc.
|
1.04B
|
Composite
62.7
Moat
66.3
|
29.54
-61.9
YoY
|
-1.4%
+0.2
YoY
|
|
NUTX
Nutex Health Inc.
|
1.03B
|
Composite
70.0
Moat
71.3
|
-
No YoY
|
31.5%
+2.8
YoY
|
|
AZTA
Azenta, Inc.
|
1.03B
|
Composite
46.5
Moat
63.5
|
40.43
No YoY
|
-3.6%
+3.3
YoY
|
|
1.01B
|
Composite
48.0
Moat
37.0
|
11.55
+3.3
YoY
|
-
No YoY
|
|
|
1.00B
|
Composite
51.8
Moat
63.5
|
19.93
+1.8
YoY
|
-
No YoY
|
|
|
1.00B
|
Composite
54.2
Moat
53.6
|
20.76
-3.8
YoY
|
-
No YoY
|
|
|
991.54M
|
Composite
52.5
Moat
45.0
|
17.21
-29.0
YoY
|
-2.1%
+1.3
YoY
|
|
|
990.20M
|
Composite
52.9
Moat
45.5
|
241.4
+122.9
YoY
|
-1.5%
+49.1
YoY
|
|
|
982.70M
|
Composite
57.5
Moat
49.0
|
176.5
No YoY
|
-7.7%
+2.8
YoY
|
|
|
CNMD
CONMED Corporation
|
979.80M
|
Composite
66.9
Moat
64.3
|
-
No YoY
|
9.5%
-5.9
YoY
|
|
AORT
Artivion, Inc.
|
977.20M
|
Composite
64.1
Moat
62.3
|
91.64
-163.7
YoY
|
6.1%
-3.9
YoY
|
|
BIOA
BioAge Labs, Inc.
|
954.40M
|
Composite
38.1
Moat
18.5
|
41.32
-41.2
YoY
|
-10.3%
No YoY
|
|
951.30M
|
Composite
55.2
Moat
60.9
|
-
No YoY
|
10.3%
+0.5
YoY
|
|
|
EVO
Evotec SE
|
949.98M
|
Composite
48.2
Moat
38.8
|
605.3
No YoY
|
-7.1%
+2.8
YoY
|
|
933.51M
|
Composite
26.3
Moat
38.2
|
7.29
+3.5
YoY
|
24.4%
+53.4
YoY
|
|
|
924.41M
|
Composite
57.4
Moat
62.7
|
30.44
+3.2
YoY
|
-
No YoY
|
|
|
923.16M
|
Composite
52.2
Moat
55.2
|
30.20
+3.0
YoY
|
-
No YoY
|
|
|
KURA
Kura Oncology, Inc.
|
919.70M
|
Composite
52.4
Moat
50.2
|
125.0
+84.2
YoY
|
-4.5%
-0.9
YoY
|
|
919.50M
|
Composite
46.2
Moat
43.1
|
19.23
+15.5
YoY
|
-
No YoY
|
|
|
PHAR
Pharming Group N.V.
|
917.37M
|
Composite
69.5
Moat
76.8
|
1122.4
+974.4
YoY
|
5.5%
+6.8
YoY
|
|
904.47M
|
Composite
54.0
Moat
44.2
|
32.89
-3.3
YoY
|
-
No YoY
|
|
|
897.80M
|
Composite
44.4
Moat
29.4
|
22.93
-10.0
YoY
|
-1236.0%
-1080.7
YoY
|
|
|
896.28M
|
Composite
67.0
Moat
40.3
|
36.62
No YoY
|
-1.1%
+5.6
YoY
|
|
|
893.60M
|
Composite
64.6
Moat
59.2
|
-
No YoY
|
2.6%
-11.3
YoY
|
|
|
892.90M
|
Composite
52.9
Moat
60.8
|
27.69
+5.0
YoY
|
-1.9%
+9.4
YoY
|
|
|
892.80M
|
Composite
61.2
Moat
59.0
|
17.02
+1.0
YoY
|
-98.2%
-91.9
YoY
|
|
|
874.52M
|
Composite
61.4
Moat
58.4
|
141.0
-139.7
YoY
|
-9.3%
-0.3
YoY
|
|
|
873.47M
|
Composite
55.2
Moat
55.8
|
41.34
-8.6
YoY
|
-
No YoY
|
|
|
TALK
Talkspace, Inc.
|
872.74M
|
Composite
59.1
Moat
45.3
|
90.70
+63.5
YoY
|
1.4%
+3.8
YoY
|
|
870.40M
|
Composite
63.7
Moat
71.1
|
-
No YoY
|
11.0%
+2.7
YoY
|
|
|
GERN
Geron Corporation
|
859.60M
|
Composite
60.3
Moat
63.4
|
38.68
+16.4
YoY
|
-28.0%
-25.8
YoY
|
|
855.66M
|
Composite
54.2
Moat
73.1
|
48.53
-19.8
YoY
|
-
No YoY
|
|
|
853.70M
|
Composite
71.4
Moat
62.6
|
91.91
+46.4
YoY
|
-3.4%
+62.6
YoY
|
|
|
849.11M
|
Composite
53.3
Moat
55.1
|
9.35
-4.0
YoY
|
-91.4%
-86.3
YoY
|
|
|
843.50M
|
Composite
45.9
Moat
37.0
|
-
No YoY
|
-33.7%
-35.3
YoY
|
|
|
INMD
InMode Ltd.
|
836.97M
|
Composite
67.7
Moat
70.7
|
-
No YoY
|
23.1%
-5.4
YoY
|
|
CERT
Certara, Inc.
|
830.72M
|
Composite
64.9
Moat
63.7
|
-
No YoY
|
5.0%
+5.5
YoY
|
|
ANNX
Annexon, Inc.
|
825.77M
|
Composite
53.0
Moat
47.6
|
15.35
-16.4
YoY
|
-
No YoY
|
|
817.10M
|
Composite
47.4
Moat
47.5
|
14.42
-3.4
YoY
|
-12.3%
-7.0
YoY
|
|
|
813.50M
|
Composite
49.8
Moat
47.8
|
153.8
+80.4
YoY
|
14.9%
-1.4
YoY
|
|
|
809.54M
|
Composite
49.6
Moat
65.4
|
38.28
+27.2
YoY
|
-
No YoY
|
|
|
808.20M
|
Composite
63.5
Moat
67.5
|
-
No YoY
|
19.5%
-8.6
YoY
|
|
|
804.70M
|
Composite
53.7
Moat
44.1
|
42.57
+13.0
YoY
|
-43.2%
+14.2
YoY
|
|
|
747.80M
|
Composite
61.6
Moat
71.6
|
1434.4
+1422.4
YoY
|
-4.0%
-0.3
YoY
|
|
|
OMER
Omeros Corporation
|
747.60M
|
Composite
43.9
Moat
44.6
|
17.76
+10.5
YoY
|
-
No YoY
|
|
HSTM
HealthStream, Inc.
|
740.90M
|
Composite
64.5
Moat
71.0
|
-
No YoY
|
6.7%
-0.6
YoY
|
|
724.82M
|
Composite
43.0
Moat
28.9
|
20.12
+2.6
YoY
|
-11703.7%
-8393.3
YoY
|
|
|
722.70M
|
Composite
55.7
Moat
51.8
|
24.38
+14.0
YoY
|
-
No YoY
|
|
|
718.10M
|
Composite
50.2
Moat
71.8
|
48.49
+5.3
YoY
|
-
No YoY
|
|
|
714.31M
|
Composite
37.4
Moat
52.1
|
26.41
+12.9
YoY
|
-29.6%
-19.4
YoY
|
|
|
EHAB
Enhabit, Inc.
|
706.56M
|
Composite
48.4
Moat
54.9
|
-
No YoY
|
6.0%
+1.5
YoY
|
|
SIBN
SI-BONE, Inc.
|
701.61M
|
Composite
55.9
Moat
61.8
|
144.9
+38.4
YoY
|
-11.1%
+10.0
YoY
|
|
699.30M
|
Composite
53.4
Moat
48.5
|
20.43
-2.3
YoY
|
-
No YoY
|
|
|
CLYM
Climb Bio, Inc.
|
697.43M
|
Composite
55.4
Moat
70.3
|
22.32
-94.1
YoY
|
-
No YoY
|
|
CRMD
CorMedix Inc.
|
691.90M
|
Composite
77.4
Moat
74.8
|
12.25
-11.5
YoY
|
48.2%
+99.6
YoY
|
|
CBLL
CeriBell, Inc.
|
684.11M
|
Composite
51.5
Moat
50.4
|
66.56
+52.4
YoY
|
-65.6%
-4.9
YoY
|
|
677.55M
|
Composite
47.0
Moat
34.5
|
38.55
+13.6
YoY
|
-
No YoY
|
|
|
661.80M
|
Composite
55.9
Moat
64.5
|
21.76
+7.8
YoY
|
-29.3%
-47.4
YoY
|
|
|
661.10M
|
Composite
73.6
Moat
70.3
|
119.0
+109.5
YoY
|
42.6%
+29.1
YoY
|
|
|
640.57M
|
Composite
55.0
Moat
66.1
|
518.5
+444.0
YoY
|
-12.4%
-15.1
YoY
|
|
|
628.80M
|
Composite
61.2
Moat
69.6
|
-
No YoY
|
40.1%
+12.9
YoY
|
|
|
628.49M
|
Composite
35.4
Moat
25.6
|
23.11
-44.8
YoY
|
-9.5%
-6.7
YoY
|
|
|
625.87M
|
Composite
45.7
Moat
38.3
|
76.85
+56.9
YoY
|
-
No YoY
|
|
|
620.78M
|
Composite
51.1
Moat
40.3
|
50.35
+35.8
YoY
|
-
No YoY
|
|
|
618.56M
|
Composite
54.8
Moat
56.9
|
114.5
+77.4
YoY
|
-
No YoY
|
|
|
BBNX
Beta Bionics, Inc.
|
610.50M
|
Composite
53.1
Moat
39.8
|
51.63
+25.9
YoY
|
-71.5%
-2.0
YoY
|
|
608.88M
|
Composite
57.6
Moat
32.9
|
37.50
-8.1
YoY
|
-277.4%
-80.2
YoY
|
|
|
PRME
Prime Medicine, Inc.
|
608.68M
|
Composite
43.3
Moat
30.7
|
13.12
-5.5
YoY
|
-45.0%
+22.9
YoY
|
|
BVS
Bioventus Inc.
|
595.51M
|
Composite
63.3
Moat
66.2
|
26.76
No YoY
|
9.9%
+5.4
YoY
|
|
592.12M
|
Composite
35.7
Moat
44.5
|
27.73
+3.7
YoY
|
-1.6%
+51.9
YoY
|
|
|
591.40M
|
Composite
69.5
Moat
71.9
|
-
No YoY
|
8.9%
+1.3
YoY
|
|
|
590.53M
|
Composite
46.8
Moat
52.7
|
29.65
+8.6
YoY
|
-1.8%
+0.4
YoY
|
|
|
BWAY
Brainsway Ltd.
|
583.56M
|
Composite
68.2
Moat
78.2
|
58.50
No YoY
|
8.3%
+4.9
YoY
|
|
MOVE
Movano Inc.
|
579.88M
|
Composite
28.0
Moat
14.7
|
3.01
-1.2
YoY
|
-35.8%
-11.9
YoY
|
|
572.49M
|
Composite
54.9
Moat
47.7
|
50.69
+22.0
YoY
|
-
No YoY
|
|
|
ALT
Altimmune, Inc.
|
569.81M
|
Composite
50.1
Moat
32.7
|
48.59
+28.8
YoY
|
-2304.6%
+2854.0
YoY
|
|
560.11M
|
Composite
67.0
Moat
71.2
|
87.90
No YoY
|
9.9%
-5.5
YoY
|
|
|
PHR
Phreesia, Inc.
|
551.36M
|
Composite
65.4
Moat
42.1
|
32.44
+8.9
YoY
|
-13.8%
+24.5
YoY
|
|
PROK
ProKidney Corp.
|
549.70M
|
Composite
48.3
Moat
29.0
|
26.98
-7.1
YoY
|
-184.8%
+2232.0
YoY
|
|
TLRY
Tilray Brands, Inc.
|
547.51M
|
Composite
47.1
Moat
36.3
|
32.52
-68.6
YoY
|
-13.1%
+1.2
YoY
|
|
MDXG
MiMedx Group, Inc
|
546.60M
|
Composite
71.8
Moat
78.2
|
44.23
-483.0
YoY
|
15.3%
-1.7
YoY
|
|
532.90M
|
Composite
45.3
Moat
39.9
|
23.03
-3.9
YoY
|
-65.4%
-2.5
YoY
|
|
|
526.70M
|
Composite
72.5
Moat
79.1
|
91.81
-9.6
YoY
|
97.6%
+186.4
YoY
|
|
|
NPCE
Neuropace, Inc.
|
524.02M
|
Composite
51.9
Moat
57.3
|
66.57
+31.3
YoY
|
-16.3%
+10.8
YoY
|
|
522.80M
|
Composite
45.5
Moat
65.8
|
9.58
-10.3
YoY
|
-1.0%
+2.8
YoY
|
|
|
CERS
Cerus Corporation
|
521.00M
|
Composite
57.0
Moat
56.2
|
18.31
-29.6
YoY
|
-4.2%
+3.7
YoY
|
|
ANGO
AngioDynamics, Inc.
|
511.90M
|
Composite
51.0
Moat
52.2
|
66.22
+33.8
YoY
|
-8.2%
+2.9
YoY
|
|
511.20M
|
Composite
44.0
Moat
35.9
|
-
No YoY
|
-19.1%
+7.0
YoY
|
|
|
NGNE
Neurogene Inc.
|
509.61M
|
Composite
44.0
Moat
28.2
|
41.83
-11.3
YoY
|
-89.3%
No YoY
|
|
504.99M
|
Composite
58.4
Moat
24.9
|
44.30
+6.4
YoY
|
-1.9%
+5074.9
YoY
|
|
|
503.90M
|
Composite
40.1
Moat
21.2
|
195.5
No YoY
|
-1.2%
-0.7
YoY
|
|
|
500.91M
|
Composite
24.9
Moat
36.5
|
16.38
-6.1
YoY
|
-7.2%
+8.1
YoY
|
|
|
VALN
Valneva SE
|
500.27M
|
Composite
51.9
Moat
65.3
|
24.88
-5.2
YoY
|
-46.7%
-0.9
YoY
|
|
ARVN
Arvinas, Inc.
|
499.39M
|
Composite
52.5
Moat
67.4
|
30.04
-18.1
YoY
|
-45.1%
+49.9
YoY
|
|
498.49M
|
Composite
44.9
Moat
58.2
|
669.7
+335.0
YoY
|
-20.0%
-9.8
YoY
|
|
|
497.90M
|
Composite
55.7
Moat
26.7
|
8.83
-5.0
YoY
|
-
No YoY
|
|
|
RZLT
Rezolute, Inc.
|
495.90M
|
Composite
60.5
Moat
61.3
|
29.16
+2.6
YoY
|
-
No YoY
|
|
CABA
Cabaletta Bio, Inc.
|
490.79M
|
Composite
50.6
Moat
34.2
|
12.23
-10.1
YoY
|
-
No YoY
|
|
490.62M
|
Composite
49.4
Moat
51.0
|
21.80
-8.2
YoY
|
-4.2%
+0.5
YoY
|
|
|
484.70M
|
Composite
50.5
Moat
64.7
|
30.54
-5.1
YoY
|
-12.3%
+2.2
YoY
|
|
|
479.00M
|
Composite
45.9
Moat
45.5
|
22.56
-15.1
YoY
|
-19.1%
-17.9
YoY
|
|
|
455.54M
|
Composite
55.6
Moat
55.4
|
30.22
-14.9
YoY
|
-2.9%
+0.4
YoY
|
|
|
454.79M
|
Composite
44.0
Moat
29.5
|
16.89
-23.5
YoY
|
-268.1%
-176.5
YoY
|
|
|
451.97M
|
Composite
63.1
Moat
50.1
|
138.1
+25.3
YoY
|
-
No YoY
|
|
|
446.68M
|
Composite
46.3
Moat
40.1
|
18.15
-4.6
YoY
|
-
No YoY
|
|
|
446.39M
|
Composite
60.2
Moat
82.6
|
57.04
-17.8
YoY
|
32.1%
No YoY
|
|
|
SOPH
SOPHiA GENETICS SA
|
439.57M
|
Composite
35.2
Moat
31.5
|
23.50
+1.0
YoY
|
-91.8%
-90.7
YoY
|
|
439.20M
|
Composite
60.4
Moat
70.8
|
-
No YoY
|
16.4%
-8.2
YoY
|
|
|
438.47M
|
Composite
67.5
Moat
21.2
|
23.71
+5.6
YoY
|
-
No YoY
|
|
|
438.44M
|
Composite
57.8
Moat
52.9
|
29.74
-13.0
YoY
|
-15.4%
No YoY
|
|
|
437.80M
|
Composite
55.4
Moat
54.1
|
-
No YoY
|
7.8%
+3.9
YoY
|
|
|
OCGN
Ocugen, Inc.
|
436.69M
|
Composite
43.9
Moat
37.0
|
3.91
-12.7
YoY
|
-14.3%
-0.8
YoY
|
|
436.60M
|
Composite
43.7
Moat
42.2
|
15.28
-42.7
YoY
|
-12.7%
-2.4
YoY
|
|
|
434.80M
|
Composite
47.6
Moat
31.7
|
22.71
-6.5
YoY
|
-3.5%
-1.6
YoY
|
|
|
429.69M
|
Composite
47.6
Moat
49.8
|
10.65
-4.8
YoY
|
-2.5%
+4.9
YoY
|
|
|
428.45M
|
Composite
51.2
Moat
35.7
|
22.00
+6.4
YoY
|
-8.6%
+11.3
YoY
|
|
|
427.49M
|
Composite
45.5
Moat
23.4
|
6.89
+1.3
YoY
|
-
No YoY
|
|
|
427.00M
|
Composite
50.8
Moat
29.0
|
46.44
No YoY
|
-79.4%
-86.1
YoY
|
|
|
425.80M
|
Composite
29.9
Moat
46.8
|
0.15
No YoY
|
-0.4%
-2.1
YoY
|
|
|
425.00M
|
Composite
41.5
Moat
60.5
|
141.2
+126.0
YoY
|
-16.9%
-6.4
YoY
|
|
|
PRTC
PureTech Health plc
|
423.21M
|
Composite
43.9
Moat
43.7
|
39.09
+6.3
YoY
|
-21.1%
+10.4
YoY
|
|
422.56M
|
Composite
51.9
Moat
36.3
|
49.73
+18.3
YoY
|
-254.4%
-9.8
YoY
|
|
|
420.92M
|
Composite
48.1
Moat
42.1
|
42.26
+24.8
YoY
|
-23.8%
-12.6
YoY
|
|
|
419.90M
|
Composite
58.5
Moat
51.1
|
21.80
+10.4
YoY
|
-5.9%
+103.5
YoY
|
|
|
416.70M
|
Composite
61.6
Moat
68.2
|
-
No YoY
|
7.7%
+0.5
YoY
|
|
|
416.00M
|
Composite
42.6
Moat
36.8
|
2.89
-11.2
YoY
|
-7.1%
+11.8
YoY
|
|
|
KMDA
Kamada Ltd.
|
414.80M
|
Composite
64.3
Moat
67.1
|
25.29
No YoY
|
14.5%
+2.1
YoY
|
|
413.01M
|
Composite
63.1
Moat
66.7
|
13.53
-7.1
YoY
|
-9.6%
+10.7
YoY
|
|
|
410.56M
|
Composite
57.2
Moat
42.6
|
106.5
+26.4
YoY
|
-12.1%
+3.3
YoY
|
|
|
405.00M
|
Composite
53.0
Moat
54.2
|
6.50
-219.6
YoY
|
13.5%
+21.5
YoY
|
|
|
404.79M
|
Composite
42.7
Moat
39.5
|
176.3
+134.0
YoY
|
-0.9%
+0.5
YoY
|
|
|
404.00M
|
Composite
46.0
Moat
31.0
|
9.52
+0.9
YoY
|
-24.7%
+18.4
YoY
|
|
|
RGNX
REGENXBIO Inc.
|
403.20M
|
Composite
55.9
Moat
57.7
|
22.27
+6.0
YoY
|
-94.6%
-91.8
YoY
|
|
401.90M
|
Composite
51.9
Moat
47.6
|
12.73
-21.5
YoY
|
-3.6%
+20.2
YoY
|
|
|
STTK
Shattuck Labs, Inc.
|
401.81M
|
Composite
49.8
Moat
34.8
|
23.49
+9.0
YoY
|
-51.5%
-37.4
YoY
|
|
399.70M
|
Composite
65.0
Moat
44.4
|
72.45
+46.1
YoY
|
-16.8%
-15.2
YoY
|
|
|
397.30M
|
Composite
68.0
Moat
68.6
|
34.20
+21.7
YoY
|
0.8%
+34.1
YoY
|
|
|
395.75M
|
Composite
45.7
Moat
33.3
|
22.13
+4.2
YoY
|
-92.5%
-62.0
YoY
|
|
|
TBRG
TruBridge, Inc.
|
391.60M
|
Composite
60.0
Moat
56.7
|
-
No YoY
|
6.0%
+4.1
YoY
|
|
389.90M
|
Composite
72.3
Moat
75.1
|
61.47
No YoY
|
16.3%
+2.9
YoY
|
|
|
AUNA
Auna SA
|
389.31M
|
Composite
49.3
Moat
63.0
|
-
No YoY
|
14.4%
-2.6
YoY
|
|
388.80M
|
Composite
62.1
Moat
68.4
|
117.6
+79.8
YoY
|
-1.3%
+0.5
YoY
|
|
|
388.60M
|
Composite
55.9
Moat
54.2
|
35.46
+26.1
YoY
|
-2.5%
+52.8
YoY
|
|
|
382.04M
|
Composite
52.0
Moat
30.6
|
14.51
-16.6
YoY
|
-
No YoY
|
|
|
VSTM
Verastem, Inc.
|
373.50M
|
Composite
48.1
Moat
38.9
|
18.66
+8.5
YoY
|
-5.5%
+6.0
YoY
|
|
368.50M
|
Composite
58.3
Moat
64.8
|
-
No YoY
|
8.2%
-0.6
YoY
|
|
|
365.80M
|
Composite
49.6
Moat
48.2
|
11.93
-9.4
YoY
|
-
No YoY
|
|
|
363.78M
|
Composite
50.3
Moat
35.6
|
51.01
+17.1
YoY
|
-66.6%
No YoY
|
|
|
361.80M
|
Composite
54.2
Moat
59.2
|
8.68
-44.0
YoY
|
-8.3%
+1.4
YoY
|
|
|
360.80M
|
Composite
55.4
Moat
68.9
|
28.93
-256.4
YoY
|
-70.0%
-49.5
YoY
|
|
|
ZURA
Zura Bio Limited
|
356.24M
|
Composite
49.8
Moat
50.7
|
20.26
-55.2
YoY
|
-
No YoY
|
|
355.67M
|
Composite
40.2
Moat
24.9
|
16.40
-9.7
YoY
|
-160.6%
-159.1
YoY
|
|
|
351.32M
|
Composite
56.0
Moat
58.8
|
27.43
-12.8
YoY
|
39.4%
No YoY
|
|
|
348.61M
|
Composite
40.7
Moat
15.5
|
7.48
+0.7
YoY
|
-
No YoY
|
|
|
347.80M
|
Composite
41.9
Moat
24.0
|
21.06
-127.8
YoY
|
-2.1%
0.0
YoY
|
|
|
342.85M
|
Composite
47.1
Moat
46.6
|
30.75
-64.7
YoY
|
-56.2%
-23.4
YoY
|
|
|
OABI
OmniAb, Inc.
|
336.34M
|
Composite
55.3
Moat
60.9
|
17.78
-0.2
YoY
|
-3.7%
-0.9
YoY
|
|
335.90M
|
Composite
39.2
Moat
49.0
|
26.11
-37.3
YoY
|
-40.5%
-38.8
YoY
|
|
|
334.39M
|
Composite
34.0
Moat
36.8
|
-
No YoY
|
-3.2%
-2.2
YoY
|
|
|
332.01M
|
Composite
38.0
Moat
31.4
|
19.08
+4.3
YoY
|
-1.9%
+1.4
YoY
|
|
|
331.50M
|
Composite
25.6
Moat
44.0
|
113.8
+93.2
YoY
|
-6.5%
+33.6
YoY
|
|
|
331.28M
|
Composite
49.8
Moat
49.5
|
15.35
+1.1
YoY
|
-2.7%
+0.4
YoY
|
|
|
331.00M
|
Composite
56.4
Moat
62.5
|
35.39
+26.1
YoY
|
-14.2%
-19.4
YoY
|
|
|
327.70M
|
Composite
67.0
Moat
47.1
|
30.09
+9.2
YoY
|
-15.4%
-1.6
YoY
|
|
|
MASS
908 Devices Inc.
|
327.47M
|
Composite
53.5
Moat
47.6
|
57.23
+29.6
YoY
|
-45.7%
+36.9
YoY
|
|
PALI
Palisade Bio, Inc.
|
319.39M
|
Composite
55.3
Moat
43.6
|
147.6
+137.9
YoY
|
-51.4%
No YoY
|
|
318.07M
|
Composite
44.0
Moat
46.6
|
0.81
+0.4
YoY
|
-48.1%
-19.4
YoY
|
|
|
ELMD
Electromed, Inc.
|
318.00M
|
Composite
71.7
Moat
82.2
|
142.6
No YoY
|
15.1%
+3.1
YoY
|
|
315.20M
|
Composite
56.0
Moat
55.8
|
24.73
+0.7
YoY
|
-
No YoY
|
|
|
314.10M
|
Composite
54.1
Moat
60.8
|
35.38
+10.5
YoY
|
-1.5%
+0.8
YoY
|
|
|
313.58M
|
Composite
52.9
Moat
60.4
|
77.20
+16.1
YoY
|
-
No YoY
|
|
|
312.68M
|
Composite
61.7
Moat
62.8
|
-
No YoY
|
7.9%
+3.5
YoY
|
|
|
310.60M
|
Composite
64.6
Moat
73.9
|
-
No YoY
|
25.1%
-25.4
YoY
|
|
|
305.86M
|
Composite
54.3
Moat
76.1
|
25.89
+18.6
YoY
|
-
No YoY
|
|
|
302.10M
|
Composite
43.2
Moat
29.3
|
24.50
-7.4
YoY
|
-1.1%
+76.2
YoY
|
|
|
294.52M
|
Composite
50.5
Moat
40.7
|
25.67
-9.9
YoY
|
-
No YoY
|
|
|
293.55M
|
Composite
55.2
Moat
67.9
|
24.48
-1.9
YoY
|
-
No YoY
|
|
|
292.35M
|
Composite
41.0
Moat
69.6
|
20.31
-87.5
YoY
|
-31.0%
+62.3
YoY
|
|
|
MGNX
MacroGenics, Inc.
|
291.10M
|
Composite
50.2
Moat
63.5
|
28.12
-7.3
YoY
|
-48.7%
+25.8
YoY
|
|
287.26M
|
Composite
59.5
Moat
32.9
|
45.74
+37.9
YoY
|
-163.3%
-147.0
YoY
|
|
|
287.00M
|
Composite
57.9
Moat
63.4
|
15.31
-6.7
YoY
|
10.0%
+41.4
YoY
|
|
|
286.40M
|
Composite
32.5
Moat
38.5
|
48.78
+20.6
YoY
|
-59.2%
-46.4
YoY
|
|
|
IVVD
Invivyd, Inc.
|
285.74M
|
Composite
64.5
Moat
65.8
|
46.79
+41.9
YoY
|
-1.0%
+5.9
YoY
|
|
SGHT
Sight Sciences, Inc.
|
285.11M
|
Composite
48.3
Moat
50.9
|
37.17
-27.5
YoY
|
-47.9%
+15.3
YoY
|
|
283.48M
|
Composite
48.2
Moat
29.3
|
10.61
-9.6
YoY
|
-
No YoY
|
|
|
IFRX
InflaRx N.V.
|
279.86M
|
Composite
41.0
Moat
15.0
|
15.79
+2.7
YoY
|
-1645.3%
-1325.5
YoY
|
|
279.31M
|
Composite
44.5
Moat
26.3
|
19.77
-7.6
YoY
|
-5600.8%
-1989.8
YoY
|
|
|
277.85M
|
Composite
51.8
Moat
52.9
|
30.19
-33.9
YoY
|
-3.4%
+2.5
YoY
|
|
|
TKNO
Alpha Teknova, Inc.
|
276.65M
|
Composite
42.7
Moat
34.2
|
29.44
+11.3
YoY
|
-41.9%
+27.4
YoY
|
|
SRZN
Surrozen, Inc.
|
269.94M
|
Composite
38.7
Moat
55.9
|
35.41
+11.9
YoY
|
-12.1%
-9.7
YoY
|
|
261.25M
|
Composite
51.7
Moat
55.5
|
23.56
-2.5
YoY
|
-2.8%
No YoY
|
|
|
260.14M
|
Composite
46.2
Moat
56.1
|
24.43
-18.3
YoY
|
-25.5%
+1.1
YoY
|
|
|
257.95M
|
Composite
43.8
Moat
62.2
|
13.62
+11.1
YoY
|
-59.7%
-58.5
YoY
|
|
|
254.76M
|
Composite
50.4
Moat
57.3
|
27.61
-93.7
YoY
|
-6.2%
-28.5
YoY
|
|
|
ADAG
Adagene Inc.
|
253.72M
|
Composite
53.9
Moat
49.1
|
57.12
+22.7
YoY
|
-2.8%
+345.6
YoY
|
|
252.10M
|
Composite
36.8
Moat
48.3
|
4.05
+1.1
YoY
|
-
No YoY
|
|
|
251.21M
|
Composite
63.3
Moat
66.5
|
70.38
-1233.6
YoY
|
-24.8%
+14.7
YoY
|
|
|
250.60M
|
Composite
51.6
Moat
38.4
|
23.04
-4.2
YoY
|
-22.2%
-7.9
YoY
|
|
|
245.42M
|
Composite
55.1
Moat
61.3
|
22.15
-7.0
YoY
|
-2.7%
+1.8
YoY
|
|
|
244.31M
|
Composite
58.0
Moat
48.7
|
26.10
+10.2
YoY
|
-1.5%
+22.8
YoY
|
|
|
ACIU
AC Immune SA
|
244.20M
|
Composite
44.2
Moat
31.0
|
15.84
-4.6
YoY
|
-19.3%
-17.4
YoY
|
|
243.79M
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
243.40M
|
Composite
63.2
Moat
68.3
|
20.67
-5.0
YoY
|
-38.9%
-37.8
YoY
|
|
|
237.60M
|
Composite
41.2
Moat
47.9
|
18.76
-9.3
YoY
|
-2.6%
+0.5
YoY
|
|
|
235.40M
|
Composite
65.8
Moat
58.4
|
31.53
-20.0
YoY
|
-
No YoY
|
|
|
231.00M
|
Composite
55.5
Moat
67.8
|
33.12
-24.0
YoY
|
-
No YoY
|
|
|
228.30M
|
Composite
52.0
Moat
42.7
|
14.91
-59.1
YoY
|
-4.3%
+37.5
YoY
|
|
|
224.80M
|
Composite
50.3
Moat
50.3
|
17.80
-191.2
YoY
|
-3.3%
-2.2
YoY
|
|
|
221.18M
|
Composite
51.2
Moat
32.1
|
1.87
-0.7
YoY
|
-47.4%
No YoY
|
|
|
219.34M
|
Composite
47.2
Moat
34.6
|
6.39
-6.2
YoY
|
-
No YoY
|
|
|
218.09M
|
Composite
49.3
Moat
41.5
|
44.47
+27.6
YoY
|
-14.9%
+66.5
YoY
|
|
|
217.54M
|
Composite
40.5
Moat
46.2
|
20.64
-8.0
YoY
|
-40.0%
-4.5
YoY
|
|
|
217.31M
|
Composite
76.3
Moat
68.5
|
41.77
+9.9
YoY
|
27.7%
+86.7
YoY
|
|
|
217.10M
|
Composite
42.7
Moat
80.4
|
73.10
+60.0
YoY
|
-
No YoY
|
|
|
216.56M
|
Composite
58.0
Moat
53.9
|
78.78
+18.9
YoY
|
-4.1%
+30.6
YoY
|
|
|
CLLS
Cellectis S.A.
|
216.40M
|
Composite
55.1
Moat
55.0
|
63.55
-35.3
YoY
|
-45.3%
-43.9
YoY
|
|
SPOK
Spok Holdings, Inc.
|
215.60M
|
Composite
62.7
Moat
73.3
|
-
No YoY
|
14.1%
-0.5
YoY
|
|
CDXS
Codexis, Inc.
|
215.40M
|
Composite
59.5
Moat
65.9
|
48.44
+30.6
YoY
|
-54.5%
+43.9
YoY
|
|
QTTB
Q32 Bio Inc.
|
214.50M
|
Composite
62.5
Moat
74.3
|
17.28
+3.5
YoY
|
31.4%
+24.2
YoY
|
|
214.00M
|
Composite
50.4
Moat
64.9
|
37.31
-10.3
YoY
|
-1.1%
+68.0
YoY
|
|
|
210.60M
|
Composite
60.6
Moat
69.4
|
-
No YoY
|
29.6%
-3.6
YoY
|
|
|
210.13M
|
Composite
50.3
Moat
33.3
|
15.81
+4.8
YoY
|
-30.8%
-11.8
YoY
|
|
|
LFMD
LifeMD, Inc.
|
208.40M
|
Composite
55.6
Moat
42.5
|
2.07
-12.9
YoY
|
-4.0%
+3.6
YoY
|
|
207.80M
|
Composite
45.9
Moat
37.2
|
481.5
+468.3
YoY
|
-9.3%
-3.7
YoY
|
|
|
PDEX
Pro-Dex, Inc.
|
205.60M
|
Composite
57.4
Moat
59.8
|
51.07
+28.3
YoY
|
16.1%
+2.7
YoY
|
|
RXST
RxSight, Inc.
|
205.33M
|
Composite
45.3
Moat
50.3
|
168.0
+131.3
YoY
|
-35.8%
-9.5
YoY
|
|
204.40M
|
Composite
43.3
Moat
64.3
|
10.23
-14.5
YoY
|
-62.1%
+20.1
YoY
|
|
|
202.50M
|
Composite
56.4
Moat
62.5
|
21.01
-28.3
YoY
|
-2.7%
-1.1
YoY
|
|
|
HITI
High Tide Inc.
|
201.03M
|
Composite
42.2
Moat
44.6
|
-
No YoY
|
2.6%
-0.3
YoY
|
|
KRRO
Korro Bio, Inc.
|
200.47M
|
Composite
42.5
Moat
33.5
|
11.48
-13.7
YoY
|
-13.7%
+26.8
YoY
|
|
NKTX
Nkarta, Inc.
|
199.61M
|
Composite
55.6
Moat
74.7
|
37.38
+5.2
YoY
|
-
No YoY
|
|
SMTI
Sanara MedTech Inc.
|
199.30M
|
Composite
41.3
Moat
61.0
|
8011.2
+7992.2
YoY
|
8.9%
+18.9
YoY
|
|
THAR
Tharimmune, Inc.
|
198.86M
|
Composite
55.4
Moat
12.2
|
3.92
-14.1
YoY
|
-
No YoY
|
|
196.49M
|
Composite
37.0
Moat
28.2
|
8.96
+2.9
YoY
|
-10.5%
+0.0
YoY
|
|
|
194.49M
|
Composite
50.4
Moat
52.0
|
23.33
+3.0
YoY
|
-
No YoY
|
|
|
194.48M
|
Composite
49.0
Moat
45.8
|
24.96
+5.5
YoY
|
-9.4%
-1.9
YoY
|
|
|
ALEC
Alector, Inc.
|
194.29M
|
Composite
44.1
Moat
43.1
|
16.69
-4.9
YoY
|
-7.4%
-6.0
YoY
|
|
IMUX
Immunic, Inc.
|
193.43M
|
Composite
46.0
Moat
34.7
|
2.17
-2.9
YoY
|
-
No YoY
|
|
CGEN
Compugen Ltd.
|
190.10M
|
Composite
72.5
Moat
64.3
|
16.95
-12.4
YoY
|
43.0%
+96.5
YoY
|
|
188.90M
|
Composite
52.0
Moat
52.9
|
461.3
No YoY
|
-9.8%
-5.6
YoY
|
|
|
HUMA
Humacyte, Inc.
|
186.34M
|
Composite
46.8
Moat
32.1
|
5.77
+0.3
YoY
|
-53.1%
No YoY
|
|
184.40M
|
Composite
36.4
Moat
50.2
|
8.91
+4.6
YoY
|
-
No YoY
|
|
|
EDAP
EDAP TMS S.A.
|
183.70M
|
Composite
32.8
Moat
27.3
|
14.96
-11.4
YoY
|
-35.0%
-3.0
YoY
|
|
MDWD
MediWound Ltd.
|
183.02M
|
Composite
59.0
Moat
53.0
|
39.56
+31.5
YoY
|
-1.5%
+94.4
YoY
|
|
STXS
Stereotaxis, Inc.
|
182.80M
|
Composite
34.5
Moat
33.1
|
11.77
-5.5
YoY
|
-68.3%
+23.6
YoY
|
|
182.48M
|
Composite
58.9
Moat
71.6
|
50.72
+8.5
YoY
|
-4.8%
+65.1
YoY
|
|
|
180.83M
|
Composite
54.3
Moat
72.0
|
15.97
+1.7
YoY
|
-20.1%
+20.1
YoY
|
|
|
180.00M
|
Composite
61.1
Moat
70.2
|
-
No YoY
|
8.3%
+3.2
YoY
|
|
|
EMBC
Embecta Corp.
|
179.76M
|
Composite
54.0
Moat
69.2
|
-
No YoY
|
27.4%
+2.0
YoY
|
|
179.36M
|
Composite
43.3
Moat
26.3
|
13.67
-12.3
YoY
|
-
No YoY
|
|
|
178.23M
|
Composite
47.7
Moat
40.2
|
25.93
-3.1
YoY
|
-40.2%
+20.9
YoY
|
|
|
177.30M
|
Composite
48.7
Moat
56.7
|
359.6
+331.4
YoY
|
-7.2%
+11.9
YoY
|
|
|
177.05M
|
Composite
48.0
Moat
31.4
|
23.24
-3.5
YoY
|
-13.2%
+19.3
YoY
|
|
|
175.71M
|
Composite
51.6
Moat
73.0
|
21.07
+3.3
YoY
|
-1.5%
+36.6
YoY
|
|
|
BDSX
Biodesix, Inc.
|
175.38M
|
Composite
36.8
Moat
54.1
|
6.47
-7.3
YoY
|
-31.5%
+16.5
YoY
|
|
INGN
Inogen, Inc
|
174.10M
|
Composite
54.7
Moat
48.2
|
476.7
+416.9
YoY
|
-8.7%
+4.0
YoY
|
|
174.00M
|
Composite
57.9
Moat
68.5
|
30.29
-375.4
YoY
|
-10.4%
-17.8
YoY
|
|
|
IPHA
Innate Pharma S.A.
|
173.31M
|
Composite
40.7
Moat
33.9
|
12.65
-127.9
YoY
|
-19.2%
-15.1
YoY
|
|
172.58M
|
Composite
46.9
Moat
38.1
|
10.31
+6.6
YoY
|
-
No YoY
|
|
|
169.20M
|
Composite
57.2
Moat
54.7
|
24.55
-23.2
YoY
|
2.9%
+14.4
YoY
|
|
|
167.90M
|
Composite
48.7
Moat
46.5
|
47.60
+26.5
YoY
|
-12.2%
+27.0
YoY
|
|
|
163.23M
|
Composite
41.9
Moat
52.9
|
12.14
-11.7
YoY
|
-
No YoY
|
|
|
162.66M
|
Composite
49.1
Moat
46.2
|
15.06
-3.1
YoY
|
-12.2%
+4.5
YoY
|
|
|
161.90M
|
Composite
64.0
Moat
62.4
|
-
No YoY
|
-0.8%
-2.2
YoY
|
|
|
159.98M
|
Composite
43.3
Moat
23.3
|
3.93
+1.9
YoY
|
-338.5%
-326.2
YoY
|
|
|
159.70M
|
Composite
43.5
Moat
35.6
|
18.37
-80.3
YoY
|
-79.2%
-40.4
YoY
|
|
|
HYPR
Hyperfine, Inc.
|
158.83M
|
Composite
39.6
Moat
36.0
|
15.06
+3.4
YoY
|
-2.7%
+0.6
YoY
|
|
158.80M
|
Composite
62.1
Moat
52.0
|
165.2
-37.3
YoY
|
-7.5%
+4.2
YoY
|
|
|
158.54M
|
Composite
55.2
Moat
37.8
|
17.68
+9.5
YoY
|
-
No YoY
|
|
|
154.00M
|
Composite
55.0
Moat
37.9
|
30.38
-12.4
YoY
|
-63.5%
No YoY
|
|
|
151.90M
|
Composite
48.0
Moat
36.9
|
27.00
No YoY
|
-14.5%
+0.5
YoY
|
|
|
150.36M
|
Composite
52.3
Moat
29.6
|
17.96
+7.4
YoY
|
-
No YoY
|
|
|
150.17M
|
Composite
50.2
Moat
61.4
|
6.63
-15.0
YoY
|
-
No YoY
|
|
|
148.70M
|
Composite
40.8
Moat
9.9
|
3.75
-25.5
YoY
|
-
No YoY
|
|
|
ACOG
Alpha Cognition Inc.
|
147.19M
|
Composite
55.4
Moat
43.8
|
38.89
-36.2
YoY
|
-2.2%
No YoY
|
|
145.40M
|
Composite
58.7
Moat
45.9
|
19.62
+4.8
YoY
|
-1.8%
+2.8
YoY
|
|
|
OWLT
Owlet, Inc.
|
145.01M
|
Composite
43.5
Moat
44.5
|
39.43
+17.8
YoY
|
-7.8%
+18.1
YoY
|
|
144.11M
|
Composite
39.6
Moat
38.1
|
17.61
+9.3
YoY
|
-11.4%
-6.3
YoY
|
|
|
143.80M
|
Composite
45.6
Moat
43.0
|
6.63
+5.0
YoY
|
-13.2%
No YoY
|
|
|
143.04M
|
Composite
42.9
Moat
34.5
|
99.25
-456.3
YoY
|
-17.5%
-11.7
YoY
|
|
|
141.09M
|
Composite
48.8
Moat
36.7
|
21.79
-8.5
YoY
|
-12.3%
-3.6
YoY
|
|
|
BGM
BGM Group Ltd.
|
140.15M
|
Composite
53.5
Moat
50.3
|
-
No YoY
|
-1.4%
+3.8
YoY
|
|
ADCT
ADC Therapeutics SA
|
138.64M
|
Composite
49.5
Moat
64.3
|
22.21
-2.1
YoY
|
-1.3%
+0.5
YoY
|
|
137.34M
|
Composite
39.1
Moat
35.8
|
33.17
+11.7
YoY
|
-42.2%
+43.3
YoY
|
|
|
GUTS
Fractyl Health, Inc.
|
136.17M
|
Composite
47.3
Moat
23.7
|
12.36
+3.1
YoY
|
-1005.7%
-582.1
YoY
|
|
PYXS
Pyxis Oncology, Inc.
|
134.95M
|
Composite
49.7
Moat
45.2
|
12.63
-13.8
YoY
|
-6.1%
-1.8
YoY
|
|
JYNT
The Joint Corp.
|
133.10M
|
Composite
47.9
Moat
49.1
|
-
No YoY
|
-1.7%
+1.8
YoY
|
|
132.00M
|
Composite
60.8
Moat
68.8
|
38.27
+11.2
YoY
|
12.0%
+14.7
YoY
|
|
|
131.70M
|
Composite
53.3
Moat
40.5
|
45.88
+13.2
YoY
|
-5.9%
+15.8
YoY
|
|
|
CVRX
CVRx, Inc.
|
131.35M
|
Composite
48.7
Moat
45.4
|
22.62
-9.9
YoY
|
-90.5%
-89.3
YoY
|
|
GNLX
Genelux Corporation
|
129.67M
|
Composite
43.1
Moat
13.2
|
6.93
-10.5
YoY
|
-4151.8%
-189.8
YoY
|
|
MXCT
MaxCyte, Inc.
|
129.62M
|
Composite
50.5
Moat
41.2
|
35.94
-31.2
YoY
|
-1.4%
-0.0
YoY
|
|
129.09M
|
Composite
70.3
Moat
66.7
|
13.87
+7.1
YoY
|
7.6%
+9.9
YoY
|
|
|
HCAT
Health Catalyst, Inc
|
127.10M
|
Composite
38.7
Moat
39.2
|
115.3
-8.4
YoY
|
-13.7%
+9.0
YoY
|
|
AGEN
Agenus Inc.
|
126.60M
|
Composite
48.0
Moat
63.0
|
0.47
-2.6
YoY
|
-18.0%
-16.8
YoY
|
|
125.93M
|
Composite
43.3
Moat
60.8
|
10.39
-37.2
YoY
|
-907.4%
-821.2
YoY
|
|
|
FONR
Fonar Corporation
|
125.10M
|
Composite
55.7
Moat
59.6
|
-
No YoY
|
11.1%
-5.0
YoY
|
|
124.30M
|
Composite
54.5
Moat
49.9
|
15.02
+7.6
YoY
|
-96.6%
-92.1
YoY
|
|
|
124.30M
|
Composite
40.4
Moat
28.4
|
72.29
+64.9
YoY
|
-
No YoY
|
|
|
124.09M
|
Composite
60.1
Moat
53.3
|
52.32
+7.6
YoY
|
-2.8%
+2.0
YoY
|
|
|
RCEL
Avita Medical, Inc.
|
124.00M
|
Composite
40.8
Moat
56.7
|
7.00
-1.8
YoY
|
-59.4%
+28.7
YoY
|
|
PEPG
PepGen Inc.
|
123.81M
|
Composite
53.5
Moat
58.0
|
21.82
+4.3
YoY
|
-
No YoY
|
|
123.70M
|
Composite
53.1
Moat
52.8
|
25.21
-2.9
YoY
|
-
No YoY
|
|
|
122.34M
|
Composite
31.9
Moat
34.5
|
10.77
-3.9
YoY
|
-490.9%
No YoY
|
|
|
114.24M
|
Composite
70.0
Moat
59.7
|
23.98
+2.9
YoY
|
-1.7%
+0.5
YoY
|
|
|
ENGN
enGene Holdings Inc.
|
113.21M
|
Composite
52.0
Moat
43.4
|
23.43
-35.8
YoY
|
-
No YoY
|
|
NNOX
NANO-X IMAGING LTD
|
112.74M
|
Composite
39.4
Moat
36.5
|
17.54
-6.5
YoY
|
-4.7%
+0.4
YoY
|
|
109.40M
|
Composite
44.0
Moat
36.3
|
3.10
-4.0
YoY
|
-
No YoY
|
|
|
XGN
Exagen Inc.
|
106.79M
|
Composite
43.7
Moat
46.2
|
28.38
+8.5
YoY
|
-21.1%
+3.4
YoY
|
|
102.30M
|
Composite
61.6
Moat
53.5
|
14.48
+5.9
YoY
|
-1.1%
+0.8
YoY
|
|
|
CBUS
Cibus, Inc.
|
99.20M
|
Composite
51.6
Moat
43.7
|
2.35
-0.6
YoY
|
-18.5%
-0.5
YoY
|
|
PYPD
PolyPid Ltd.
|
98.36M
|
Composite
48.5
Moat
22.1
|
5.57
-3.0
YoY
|
-
No YoY
|
|
VANI
Vivani Medical, Inc.
|
97.45M
|
Composite
49.8
Moat
47.6
|
8.01
-2.6
YoY
|
-
No YoY
|
|
96.90M
|
Composite
58.5
Moat
57.2
|
20.52
+11.4
YoY
|
-33.6%
-24.9
YoY
|
|
|
SEER
Seer, Inc.
|
96.77M
|
Composite
55.9
Moat
56.6
|
50.19
-11.3
YoY
|
-4.8%
+2.3
YoY
|
|
95.77M
|
Composite
46.6
Moat
50.8
|
2.62
-3.3
YoY
|
-
No YoY
|
|
|
95.60M
|
Composite
53.4
Moat
61.7
|
2.00
-5.4
YoY
|
29.7%
+94.4
YoY
|
|
|
95.20M
|
Composite
36.1
Moat
48.8
|
5.29
+4.1
YoY
|
-3.5%
+23.1
YoY
|
|
|
94.20M
|
Composite
49.7
Moat
34.8
|
25.39
-7.2
YoY
|
-52.4%
-26.8
YoY
|
|
|
92.60M
|
Composite
46.2
Moat
51.5
|
19.96
+16.0
YoY
|
-
No YoY
|
|
|
92.26M
|
Composite
71.0
Moat
84.9
|
18.99
-4.6
YoY
|
28.4%
No YoY
|
|
|
91.30M
|
Composite
38.8
Moat
22.3
|
7.92
-2.9
YoY
|
-1328.7%
-812.5
YoY
|
|
|
90.46M
|
Composite
44.9
Moat
39.7
|
43.76
+27.4
YoY
|
-55.8%
+43.9
YoY
|
|
|
CCLD
CareCloud, Inc.
|
90.10M
|
Composite
67.0
Moat
68.2
|
-
No YoY
|
9.5%
+0.8
YoY
|
|
NRXS
Neuraxis, Inc.
|
88.67M
|
Composite
54.8
Moat
48.0
|
9.26
+2.0
YoY
|
-2.2%
+0.5
YoY
|
|
88.50M
|
Composite
54.1
Moat
48.4
|
42.61
+30.6
YoY
|
-3.5%
No YoY
|
|
|
ICCC
ImmuCell Corporation
|
88.16M
|
Composite
68.5
Moat
69.6
|
2.51
-42.5
YoY
|
6.0%
+12.2
YoY
|
|
88.03M
|
Composite
58.1
Moat
27.3
|
3.00
+3.0
YoY
|
-
No YoY
|
|
|
87.80M
|
Composite
54.8
Moat
67.4
|
22.96
No YoY
|
11.0%
+17.8
YoY
|
|
|
86.80M
|
Composite
63.1
Moat
73.8
|
5.12
No YoY
|
8.5%
+22.3
YoY
|
|
|
IBIO
iBio, Inc.
|
86.44M
|
Composite
49.1
Moat
37.1
|
6.73
-2.5
YoY
|
-46.5%
+27.4
YoY
|
|
ACET
Adicet Bio, Inc.
|
86.42M
|
Composite
46.4
Moat
54.5
|
19.97
-2.9
YoY
|
-2.9%
+3.4
YoY
|
|
85.98M
|
Composite
32.4
Moat
9.5
|
3.84
-3.6
YoY
|
-47.1%
No YoY
|
|
|
85.74M
|
Composite
58.3
Moat
67.2
|
24.37
No YoY
|
-4.9%
-2.4
YoY
|
|
|
BMEA
Biomea Fusion, Inc.
|
85.31M
|
Composite
49.2
Moat
35.6
|
9.52
+3.7
YoY
|
-
No YoY
|
|
85.20M
|
Composite
49.4
Moat
17.3
|
1.99
-4.9
YoY
|
-
No YoY
|
|
|
85.12M
|
Composite
47.7
Moat
11.0
|
5.51
-1.8
YoY
|
-
No YoY
|
|
|
84.51M
|
Composite
34.9
Moat
33.3
|
14.79
+1.0
YoY
|
-1.4%
+0.4
YoY
|
|
|
RLYB
Rallybio Corporation
|
84.26M
|
Composite
55.9
Moat
40.1
|
22.03
+6.1
YoY
|
-38.5%
+56.6
YoY
|
|
STIM
Neuronetics, Inc.
|
83.51M
|
Composite
41.1
Moat
45.6
|
16.70
+9.5
YoY
|
-21.1%
+25.1
YoY
|
|
83.50M
|
Composite
62.5
Moat
46.8
|
352.1
No YoY
|
-6.3%
+10.7
YoY
|
|
|
82.70M
|
Composite
47.3
Moat
36.3
|
18.45
-10.8
YoY
|
-82.6%
-11.3
YoY
|
|
|
OKYO
OKYO Pharma Limited
|
82.39M
|
Composite
44.3
Moat
60.0
|
10.34
+9.3
YoY
|
-
No YoY
|
|
GOSS
Gossamer Bio, Inc.
|
82.13M
|
Composite
45.5
Moat
52.2
|
9.59
-1009.5
YoY
|
-3.4%
+48.9
YoY
|
|
81.52M
|
Composite
42.0
Moat
57.5
|
201.8
+134.2
YoY
|
-10.2%
+52.3
YoY
|
|
|
81.20M
|
Composite
56.7
Moat
72.0
|
20.28
-11.3
YoY
|
-1.6%
+6.3
YoY
|
|
|
81.06M
|
Composite
44.2
Moat
66.0
|
0.23
-8.9
YoY
|
-
No YoY
|
|
|
79.20M
|
Composite
47.6
Moat
37.6
|
-
No YoY
|
-92.9%
-89.0
YoY
|
|
|
78.91M
|
Composite
46.5
Moat
29.3
|
13.54
+6.9
YoY
|
-403.3%
-276.4
YoY
|
|
|
78.17M
|
Composite
51.7
Moat
35.8
|
31.88
+22.5
YoY
|
-23.5%
+24.8
YoY
|
|
|
77.90M
|
Composite
17.2
Moat
33.8
|
3.29
-0.9
YoY
|
-18.5%
+2.3
YoY
|
|
|
76.53M
|
Composite
32.9
Moat
41.1
|
2.24
-0.6
YoY
|
-2.0%
-0.4
YoY
|
|
|
76.16M
|
Composite
44.1
Moat
42.9
|
6.03
+0.3
YoY
|
-
No YoY
|
|
|
ANVS
Annovis Bio, Inc.
|
75.30M
|
Composite
46.7
Moat
31.4
|
9.15
+3.4
YoY
|
-
No YoY
|
|
72.44M
|
Composite
41.3
Moat
14.1
|
18.36
-20.7
YoY
|
-450.7%
+25.1
YoY
|
|
|
72.19M
|
Composite
48.5
Moat
58.3
|
2.59
-4.9
YoY
|
-2.7%
-1.0
YoY
|
|
|
71.98M
|
Composite
61.1
Moat
63.8
|
14.48
+5.9
YoY
|
-1.1%
+0.8
YoY
|
|
|
71.83M
|
Composite
44.3
Moat
39.9
|
17.85
-9.6
YoY
|
-116.5%
-103.4
YoY
|
|
|
71.70M
|
Composite
61.4
Moat
60.3
|
7.82
-1.0
YoY
|
-45.3%
+18.2
YoY
|
|
|
NYXH
Nyxoah SA
|
70.56M
|
Composite
29.6
Moat
43.8
|
8.35
-12.5
YoY
|
-8.3%
+4.7
YoY
|
|
XBIT
XBiotech Inc.
|
70.40M
|
Composite
47.6
Moat
49.7
|
37.74
-29.2
YoY
|
-8.6%
-7.2
YoY
|
|
69.60M
|
Composite
58.4
Moat
59.0
|
13.20
-4.5
YoY
|
-
No YoY
|
|
|
LNSR
LENSAR, Inc.
|
69.48M
|
Composite
43.5
Moat
43.9
|
14.55
-103.9
YoY
|
-42.1%
-29.1
YoY
|
|
69.45M
|
Composite
53.1
Moat
41.7
|
8.86
+7.9
YoY
|
-9.6%
+177.7
YoY
|
|
|
EXOZ
eXoZymes, Inc.
|
69.36M
|
Composite
50.9
Moat
42.4
|
5.61
-8.1
YoY
|
-
No YoY
|
|
BTMD
Biote Corp.
|
68.55M
|
Composite
52.0
Moat
63.7
|
103.8
No YoY
|
18.5%
+2.5
YoY
|
|
67.63M
|
Composite
51.6
Moat
59.8
|
22.35
-10.4
YoY
|
-
No YoY
|
|
|
FORA
Forian Inc.
|
67.60M
|
Composite
56.2
Moat
40.3
|
28.24
+6.6
YoY
|
-8.2%
+19.4
YoY
|
|
ECOR
electroCore, Inc.
|
67.40M
|
Composite
37.0
Moat
50.5
|
17.02
-3.7
YoY
|
-41.1%
+7.2
YoY
|
|
KALA
KALA BIO, Inc.
|
67.10M
|
Composite
36.2
Moat
37.0
|
2.83
-18.1
YoY
|
-20.9%
-11.2
YoY
|
|
BYSI
BeyondSpring, Inc.
|
66.40M
|
Composite
54.5
Moat
44.1
|
7.62
+5.5
YoY
|
-27.6%
+21.5
YoY
|
|
65.83M
|
Composite
47.0
Moat
29.0
|
8.58
No YoY
|
-
No YoY
|
|
|
CING
Cingulate Inc.
|
65.58M
|
Composite
49.4
Moat
14.3
|
7.62
-0.3
YoY
|
-
No YoY
|
|
MNOV
MediciNova, Inc.
|
65.00M
|
Composite
50.3
Moat
39.9
|
37.68
-7.8
YoY
|
-32.4%
-22.5
YoY
|
|
63.90M
|
Composite
63.9
Moat
33.3
|
2.49
-10.6
YoY
|
-119.1%
-74.6
YoY
|
|
|
61.30M
|
Composite
27.8
Moat
29.0
|
1.19
-6.7
YoY
|
-1.0%
+57.3
YoY
|
|
|
61.20M
|
Composite
64.3
Moat
65.6
|
6.25
-1.0
YoY
|
5.4%
+15.7
YoY
|
|
|
61.03M
|
Composite
51.3
Moat
55.3
|
27.06
+21.3
YoY
|
-
No YoY
|
|
|
60.80M
|
Composite
52.4
Moat
56.9
|
18.42
-21.2
YoY
|
-
No YoY
|
|
|
EDSA
Edesa Biotech, Inc.
|
60.55M
|
Composite
56.9
Moat
33.5
|
17.69
+15.1
YoY
|
-47362.7%
No YoY
|
|
ENTX
Entera Bio Ltd.
|
59.56M
|
Composite
48.0
Moat
30.2
|
11.57
-3.7
YoY
|
-274.5%
-221.5
YoY
|
|
59.21M
|
Composite
35.6
Moat
31.0
|
6.00
+4.2
YoY
|
-29.1%
-14.8
YoY
|
|
|
57.87M
|
Composite
51.8
Moat
54.7
|
30.01
-47.8
YoY
|
-
No YoY
|
|
|
57.37M
|
Composite
43.8
Moat
23.9
|
0.02
-6.1
YoY
|
-133.4%
-65.4
YoY
|
|
|
57.25M
|
Composite
56.5
Moat
57.3
|
1.00
-7.2
YoY
|
-50.8%
-11.6
YoY
|
|
|
INCR
Intercure Ltd.
|
56.98M
|
Composite
47.2
Moat
43.1
|
14.10
-8.6
YoY
|
2.5%
+21.3
YoY
|
|
56.82M
|
Composite
56.9
Moat
60.9
|
-
No YoY
|
29.2%
+3.4
YoY
|
|
|
56.53M
|
Composite
47.5
Moat
40.4
|
13.52
-17.9
YoY
|
-13.2%
+34.7
YoY
|
|
|
56.21M
|
Composite
54.1
Moat
22.9
|
0.26
+0.2
YoY
|
-
No YoY
|
|
|
IMMP
Immutep Limited
|
55.60M
|
Composite
49.7
Moat
36.6
|
62.68
+21.4
YoY
|
-25.1%
+173.5
YoY
|
|
MDAI
Spectral AI, Inc.
|
55.06M
|
Composite
41.7
Moat
46.9
|
18.62
+11.9
YoY
|
-43.8%
-21.5
YoY
|
|
53.86M
|
Composite
50.0
Moat
50.6
|
16.66
-4.7
YoY
|
-15.0%
No YoY
|
|
|
53.49M
|
Composite
59.9
Moat
54.2
|
330.6
+294.5
YoY
|
-95.9%
-86.5
YoY
|
|
|
52.53M
|
Composite
46.5
Moat
42.0
|
11.55
-2.7
YoY
|
-
No YoY
|
|
|
52.13M
|
Composite
52.7
Moat
47.2
|
5.01
-15.3
YoY
|
-
No YoY
|
|
|
51.88M
|
Composite
44.3
Moat
41.1
|
15.88
-9.6
YoY
|
-76.5%
-73.8
YoY
|
|
|
DCGO
DocGo Inc.
|
51.72M
|
Composite
32.5
Moat
58.2
|
11.08
-1070.6
YoY
|
-27.7%
-32.3
YoY
|
|
TLPH
Talphera, Inc.
|
51.00M
|
Composite
40.7
Moat
12.4
|
21.52
+13.1
YoY
|
-481.6%
-455.6
YoY
|
|
TIL
Instil Bio, Inc.
|
50.86M
|
Composite
51.4
Moat
67.2
|
24.95
+0.5
YoY
|
-
No YoY
|
|
50.79M
|
Composite
27.7
Moat
17.4
|
11.34
+9.8
YoY
|
-65.1%
No YoY
|
|
|
DRIO
DarioHealth Corp.
|
50.70M
|
Composite
36.8
Moat
28.3
|
12.04
+3.2
YoY
|
-1.6%
+0.5
YoY
|
|
APLM
Apollomics Inc.
|
50.14M
|
Composite
43.4
Moat
53.1
|
3.79
-0.3
YoY
|
-1.1%
No YoY
|
|
ATHA
Athira Pharma, Inc.
|
50.13M
|
Composite
54.9
Moat
38.1
|
6.33
-11.2
YoY
|
-
No YoY
|
|
LTRN
Lantern Pharma Inc.
|
49.31M
|
Composite
47.7
Moat
31.4
|
7.75
-8.4
YoY
|
-
No YoY
|
|
49.10M
|
Composite
59.3
Moat
46.4
|
4.89
+3.2
YoY
|
1.1%
+0.8
YoY
|
|
|
COCH
Envoy Medical, Inc.
|
48.74M
|
Composite
35.0
Moat
23.8
|
2.47
-1.2
YoY
|
-92.4%
-6.8
YoY
|
|
48.32M
|
Composite
25.9
Moat
45.0
|
2.27
+1.0
YoY
|
-9.0%
-7.4
YoY
|
|
|
MYO
Myomo Inc.
|
48.30M
|
Composite
41.5
Moat
39.4
|
15.21
-75.5
YoY
|
-35.2%
-16.1
YoY
|
|
48.09M
|
Composite
48.8
Moat
15.5
|
8.22
+3.5
YoY
|
-
No YoY
|
|
|
VERU
Veru Inc.
|
47.50M
|
Composite
56.8
Moat
43.1
|
7.32
-6.9
YoY
|
-5.9%
-3.7
YoY
|
|
ELUT
Elutia, Inc.
|
46.86M
|
Composite
41.2
Moat
25.8
|
9.73
+2.7
YoY
|
-1.5%
+98.1
YoY
|
|
ATYR
aTyr Pharma, Inc.
|
46.10M
|
Composite
42.4
Moat
28.1
|
15.23
+2.7
YoY
|
-408.6%
-119.6
YoY
|
|
45.90M
|
Composite
52.0
Moat
47.4
|
318.5
+189.0
YoY
|
-37.5%
-56.9
YoY
|
|
|
45.29M
|
Composite
57.6
Moat
62.0
|
49.18
+24.8
YoY
|
-
No YoY
|
|
|
MGX
Metagenomi, Inc.
|
44.80M
|
Composite
54.3
Moat
45.5
|
27.32
-8.3
YoY
|
-1.7%
+0.1
YoY
|
|
ZTEK
Zentek Ltd.
|
42.90M
|
Composite
36.5
Moat
31.9
|
0.23
-5.0
YoY
|
-11.0%
+390.7
YoY
|
|
42.76M
|
Composite
36.2
Moat
24.1
|
1.71
+0.3
YoY
|
-35.8%
+28.5
YoY
|
|
|
41.60M
|
Composite
42.2
Moat
45.8
|
23.22
-50.0
YoY
|
-2.1%
+0.6
YoY
|
|
|
PRPO
Precipio, Inc.
|
41.50M
|
Composite
60.2
Moat
45.0
|
5.06
-0.3
YoY
|
-1.2%
+21.5
YoY
|
|
41.12M
|
Composite
47.9
Moat
58.6
|
1.28
-0.3
YoY
|
-
No YoY
|
|
|
RNXT
RenovoRx, Inc.
|
41.05M
|
Composite
52.6
Moat
32.1
|
7.68
-1.7
YoY
|
-11.1%
+244.0
YoY
|
|
40.20M
|
Composite
43.6
Moat
44.6
|
9.30
+6.2
YoY
|
-
No YoY
|
|
|
40.10M
|
Composite
37.0
Moat
33.1
|
5.92
+0.9
YoY
|
-78.3%
-49.7
YoY
|
|
|
39.98M
|
Composite
27.0
Moat
24.7
|
28.39
+22.3
YoY
|
-
No YoY
|
|
|
BEAT
Heartbeam, Inc.
|
39.42M
|
Composite
32.1
Moat
9.0
|
3.76
+1.8
YoY
|
-
No YoY
|
|
CRVO
CervoMed Inc.
|
39.26M
|
Composite
51.0
Moat
33.9
|
10.68
-17.6
YoY
|
-
No YoY
|
|
38.88M
|
Composite
41.2
Moat
18.8
|
4.44
-20.3
YoY
|
-276.6%
+1274.0
YoY
|
|
|
38.70M
|
Composite
58.4
Moat
73.7
|
17.82
-4.6
YoY
|
-83.8%
No YoY
|
|
|
INMB
INmune Bio Inc.
|
38.55M
|
Composite
44.8
Moat
25.5
|
13.15
+5.6
YoY
|
-617.4%
+2428.0
YoY
|
|
NTRB
Nutriband Inc.
|
37.80M
|
Composite
44.8
Moat
48.1
|
11.18
+9.5
YoY
|
-3.1%
-0.8
YoY
|
|
SCYX
SCYNEXIS, Inc.
|
37.74M
|
Composite
52.2
Moat
25.1
|
90.93
+61.3
YoY
|
-78.0%
-68.1
YoY
|
|
PETS
PetMed Express, Inc.
|
37.40M
|
Composite
24.4
Moat
42.2
|
-
No YoY
|
-3.0%
-5.4
YoY
|
|
ARAY
Accuray Incorporated
|
37.20M
|
Composite
49.9
Moat
52.3
|
69.12
-374.6
YoY
|
1.7%
+1.6
YoY
|
|
SNPX
Synaptogenix, Inc.
|
36.76M
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
TELA
TELA Bio, Inc.
|
35.86M
|
Composite
40.0
Moat
48.8
|
21.62
+6.4
YoY
|
-42.0%
+18.1
YoY
|
|
35.75M
|
Composite
37.8
Moat
37.8
|
0.22
-1.1
YoY
|
-11.5%
-6.6
YoY
|
|
|
PAVM
PAVmed Inc.
|
35.70M
|
Composite
41.0
Moat
14.6
|
3.55
+3.1
YoY
|
-301.3%
-286.5
YoY
|
|
35.54M
|
Composite
59.2
Moat
55.9
|
-
No YoY
|
8.8%
-0.4
YoY
|
|
|
35.21M
|
Composite
43.4
Moat
36.6
|
11.32
+2.9
YoY
|
-40.2%
-17.7
YoY
|
|
|
ABVC
ABVC Biopharma, Inc.
|
34.30M
|
Composite
55.6
Moat
46.3
|
3.00
+0.9
YoY
|
-9.2%
+35.2
YoY
|
|
NEPH
Nephros, Inc.
|
34.20M
|
Composite
61.0
Moat
64.3
|
91.71
+78.2
YoY
|
6.1%
+6.1
YoY
|
|
NSPR
InspireMD Inc.
|
33.50M
|
Composite
38.9
Moat
21.6
|
18.53
-0.5
YoY
|
-5.5%
-0.7
YoY
|
|
32.70M
|
Composite
28.7
Moat
40.6
|
4.58
-8.8
YoY
|
-63.5%
+14.8
YoY
|
|
|
32.65M
|
Composite
39.0
Moat
63.9
|
1.59
-4.1
YoY
|
-1.1%
-42.5
YoY
|
|
|
YI
111, Inc.
|
32.55M
|
Composite
34.5
Moat
41.4
|
17.54
-438.3
YoY
|
-0.0%
-0.0
YoY
|
|
32.30M
|
Composite
42.1
Moat
29.8
|
23.43
-3.0
YoY
|
-402.7%
+238.2
YoY
|
|
|
BOLD
Boundless Bio, Inc.
|
32.12M
|
Composite
48.4
Moat
47.3
|
27.67
-2.3
YoY
|
-
No YoY
|
|
31.60M
|
Composite
44.8
Moat
29.3
|
12.01
-7.4
YoY
|
-107.1%
-84.7
YoY
|
|
|
31.20M
|
Composite
44.9
Moat
23.3
|
16.13
-8.3
YoY
|
-74.5%
-73.5
YoY
|
|
|
31.12M
|
Composite
43.4
Moat
39.5
|
12.43
-7.7
YoY
|
-
No YoY
|
|
|
30.70M
|
Composite
51.8
Moat
35.0
|
30.00
+26.8
YoY
|
-13.2%
+2383.8
YoY
|
|
|
30.50M
|
Composite
33.3
Moat
51.1
|
-
No YoY
|
1.5%
-10.3
YoY
|
|
|
ONMD
OneMedNet Corp
|
30.44M
|
Composite
34.3
Moat
17.4
|
1.74
-3.4
YoY
|
-7.1%
+7.8
YoY
|
|
30.35M
|
Composite
39.9
Moat
22.5
|
4.54
-9.5
YoY
|
-2896.7%
-2862.9
YoY
|
|
|
28.60M
|
Composite
50.9
Moat
44.3
|
15.41
-12.6
YoY
|
-5.8%
-4.1
YoY
|
|
|
28.60M
|
Composite
49.8
Moat
44.9
|
27.79
+26.2
YoY
|
-46.5%
-43.0
YoY
|
|
|
NNVC
NanoViricides, Inc.
|
28.60M
|
Composite
59.9
Moat
26.9
|
2.21
-6.9
YoY
|
-
No YoY
|
|
EVAX
Evaxion Biotech A/S
|
28.52M
|
Composite
61.1
Moat
61.8
|
42.08
+37.4
YoY
|
-1.2%
+3.2
YoY
|
|
28.51M
|
Composite
44.6
Moat
56.3
|
17.62
-28.3
YoY
|
-3.5%
+96.9
YoY
|
|
|
28.35M
|
Composite
40.3
Moat
23.7
|
3.19
+0.6
YoY
|
-304.4%
-205.2
YoY
|
|
|
FGEN
FibroGen, Inc
|
27.90M
|
Composite
56.3
Moat
54.0
|
4.39
-3.4
YoY
|
-4.4%
+2.2
YoY
|
|
27.89M
|
Composite
37.9
Moat
19.6
|
0.26
-3.7
YoY
|
-
No YoY
|
|
|
27.87M
|
Composite
39.6
Moat
30.0
|
10.00
+2.1
YoY
|
-
No YoY
|
|
|
27.40M
|
Composite
48.6
Moat
47.8
|
4.97
+0.9
YoY
|
-
No YoY
|
|
|
IGC
IGC Pharma, Inc.
|
26.70M
|
Composite
53.4
Moat
43.0
|
1.01
-1.8
YoY
|
-5.9%
+1.4
YoY
|
|
26.50M
|
Composite
40.9
Moat
50.9
|
-
No YoY
|
0.1%
+6.7
YoY
|
|
|
26.40M
|
Composite
44.8
Moat
42.8
|
455.2
+441.2
YoY
|
-6.8%
-7.4
YoY
|
|
|
26.30M
|
Composite
45.3
Moat
31.6
|
22.94
-32.5
YoY
|
-115.2%
-84.1
YoY
|
|
|
26.20M
|
Composite
42.0
Moat
39.0
|
0.43
-10.3
YoY
|
-
No YoY
|
|
|
NKGN
NKGen Biotech, Inc.
|
26.12M
|
Composite
41.6
Moat
26.5
|
0.01
-0.0
YoY
|
-316.2%
-264.9
YoY
|
|
25.90M
|
Composite
44.6
Moat
48.5
|
6.06
+3.3
YoY
|
-38.4%
+8.7
YoY
|
|
|
MEIP
MEI Pharma, Inc.
|
25.70M
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
MDXH
MDxHealth SA
|
25.55M
|
Composite
42.7
Moat
52.7
|
159.2
+128.8
YoY
|
-14.2%
+12.4
YoY
|
|
LGVN
Longeveron Inc.
|
24.93M
|
Composite
41.5
Moat
34.1
|
3.00
-13.6
YoY
|
-19.4%
-12.5
YoY
|
|
24.90M
|
Composite
39.9
Moat
27.9
|
7.17
-25.4
YoY
|
-
No YoY
|
|
|
PLRZ
Polyrizon Ltd.
|
24.69M
|
Composite
52.8
Moat
43.4
|
33.03
+6.3
YoY
|
-
No YoY
|
|
AYTU
Aytu BioPharma, Inc.
|
24.10M
|
Composite
43.5
Moat
48.0
|
191.8
+18.8
YoY
|
3.8%
+3.0
YoY
|
|
24.00M
|
Composite
57.2
Moat
60.7
|
10.31
+0.4
YoY
|
-7.2%
+73.7
YoY
|
|
|
23.10M
|
Composite
33.5
Moat
24.2
|
17.71
+7.1
YoY
|
-52.0%
-50.6
YoY
|
|
|
22.80M
|
Composite
54.1
Moat
51.9
|
16.05
-5.1
YoY
|
-68.7%
-65.3
YoY
|
|
|
TXMD
TherapeuticsMD, Inc.
|
22.60M
|
Composite
64.2
Moat
49.2
|
2.25
-3.2
YoY
|
-1.4%
+0.6
YoY
|
|
CELU
Celularity Inc.
|
21.94M
|
Composite
43.3
Moat
57.6
|
5.59
+4.2
YoY
|
-2.3%
+68.8
YoY
|
|
PLUR
Pluri Inc.
|
21.80M
|
Composite
43.7
Moat
39.0
|
13.58
-6.4
YoY
|
-16.6%
+51.4
YoY
|
|
21.66M
|
Composite
47.8
Moat
42.3
|
10.51
-11.2
YoY
|
-52.2%
+34.9
YoY
|
|
|
21.64M
|
Composite
46.9
Moat
21.5
|
11.89
-1.6
YoY
|
-39.4%
No YoY
|
|
|
21.04M
|
Composite
44.6
Moat
36.2
|
7.88
-4.2
YoY
|
-
No YoY
|
|
|
20.90M
|
Composite
42.3
Moat
46.1
|
1.44
-2.2
YoY
|
-6.7%
+0.2
YoY
|
|
|
20.50M
|
Composite
40.0
Moat
19.4
|
6.85
+1.0
YoY
|
-
No YoY
|
|
|
IRIX
IRIDEX Corporation
|
20.50M
|
Composite
47.3
Moat
41.2
|
34.20
+30.3
YoY
|
-4.9%
+12.2
YoY
|
|
20.10M
|
Composite
32.0
Moat
29.2
|
62.80
+16.5
YoY
|
-37.3%
+8.7
YoY
|
|
|
LFWD
Lifeward Ltd.
|
19.45M
|
Composite
32.2
Moat
35.2
|
1.55
-2.2
YoY
|
-76.7%
-0.5
YoY
|
|
LPCN
Lipocine Inc.
|
19.20M
|
Composite
49.0
Moat
41.0
|
18.36
-194.2
YoY
|
-5.2%
+5.1
YoY
|
|
19.02M
|
Composite
53.5
Moat
43.4
|
266.0
No YoY
|
2.9%
-12.5
YoY
|
|
|
18.51M
|
Composite
42.9
Moat
22.7
|
3.45
-7.5
YoY
|
-
No YoY
|
|
|
GTBP
GT Biopharma, Inc.
|
18.50M
|
Composite
49.1
Moat
16.6
|
6.33
+2.7
YoY
|
-
No YoY
|
|
PASG
Passage Bio, Inc.
|
18.35M
|
Composite
49.5
Moat
35.1
|
17.63
-1.6
YoY
|
-
No YoY
|
|
18.01M
|
Composite
54.0
Moat
36.2
|
43.51
+37.5
YoY
|
-299.3%
No YoY
|
|
|
17.65M
|
Composite
56.8
Moat
40.9
|
7.68
+4.7
YoY
|
-
No YoY
|
|
|
AEON
AEON Biopharma, Inc.
|
17.57M
|
Composite
35.8
Moat
50.4
|
2.08
+2.1
YoY
|
-
No YoY
|
|
XCUR
Exicure, Inc.
|
17.50M
|
Composite
43.7
Moat
40.8
|
5.25
-46.3
YoY
|
-9.9%
-3.5
YoY
|
|
17.07M
|
Composite
45.6
Moat
36.6
|
11.35
-12.4
YoY
|
-39.0%
-37.0
YoY
|
|
|
CRIS
Curis, Inc.
|
16.70M
|
Composite
50.9
Moat
57.8
|
2.23
-3.8
YoY
|
-3.5%
+0.6
YoY
|
|
MLEC
Moolec Science SA
|
16.62M
|
Composite
44.2
Moat
64.8
|
0.83
-6.1
YoY
|
-1.1%
-10.0
YoY
|
|
16.60M
|
Composite
42.7
Moat
33.0
|
4.69
+2.5
YoY
|
-
No YoY
|
|
|
AIMD
Ainos, Inc.
|
15.90M
|
Composite
32.3
Moat
33.3
|
1.09
-7.0
YoY
|
-112.7%
+555.0
YoY
|
|
15.80M
|
Composite
45.7
Moat
39.9
|
16.65
-23.9
YoY
|
-
No YoY
|
|
|
15.60M
|
Composite
56.3
Moat
44.2
|
1.92
+0.5
YoY
|
-
No YoY
|
|
|
15.52M
|
Composite
25.7
Moat
19.0
|
5.97
+5.7
YoY
|
-37.6%
+69.9
YoY
|
|
|
ICCM
IceCure Medical Ltd.
|
15.16M
|
Composite
36.7
Moat
30.4
|
7.33
+0.1
YoY
|
-4.5%
+0.3
YoY
|
|
15.12M
|
Composite
39.2
Moat
43.2
|
5.14
-10.2
YoY
|
-
No YoY
|
|
|
15.10M
|
Composite
36.6
Moat
15.8
|
10.80
+2.4
YoY
|
-232.3%
-139.1
YoY
|
|
|
FLGC
Flora Growth Corp.
|
15.02M
|
Composite
50.0
Moat
25.0
|
14.35
+8.1
YoY
|
-21.8%
-7.9
YoY
|
|
14.50M
|
Composite
44.6
Moat
36.9
|
2.26
-13.6
YoY
|
-16.8%
-4.4
YoY
|
|
|
14.40M
|
Composite
41.4
Moat
33.8
|
92.60
+17.5
YoY
|
-1.5%
-0.2
YoY
|
|
|
14.27M
|
Composite
57.5
Moat
52.1
|
21.98
+17.4
YoY
|
-
No YoY
|
|
|
14.20M
|
Composite
23.1
Moat
15.1
|
3.44
-9.1
YoY
|
-
No YoY
|
|
|
BLRX
BioLineRx Ltd.
|
14.10M
|
Composite
58.7
Moat
47.7
|
31.03
+25.7
YoY
|
-8.7%
+57.5
YoY
|
|
INAB
IN8bio, Inc.
|
14.08M
|
Composite
56.2
Moat
48.6
|
25.57
+20.0
YoY
|
-
No YoY
|
|
14.04M
|
Composite
46.7
Moat
36.2
|
4.46
-9.3
YoY
|
-
No YoY
|
|
|
HOOK
HOOKIPA Pharma Inc.
|
13.86M
|
Composite
58.0
Moat
59.7
|
6.19
-18.2
YoY
|
-85.1%
-81.4
YoY
|
|
BFRI
Biofrontera Inc.
|
13.83M
|
Composite
40.3
Moat
37.6
|
5.75
-1.2
YoY
|
-27.2%
+18.9
YoY
|
|
13.80M
|
Composite
40.5
Moat
29.7
|
10.29
+3.1
YoY
|
-
No YoY
|
|
|
13.66M
|
Composite
59.1
Moat
60.2
|
11.73
+2.8
YoY
|
-2.4%
-0.6
YoY
|
|
|
TRAW
Traws Pharma, Inc.
|
13.51M
|
Composite
51.0
Moat
50.6
|
2.52
-6.1
YoY
|
-6.4%
+103.8
YoY
|
|
BIVI
BioVie Inc.
|
13.30M
|
Composite
50.9
Moat
37.2
|
11.07
+0.8
YoY
|
-
No YoY
|
|
13.20M
|
Composite
32.9
Moat
36.8
|
14.15
+12.5
YoY
|
-1.2%
+1.3
YoY
|
|
|
12.85M
|
Composite
49.7
Moat
23.3
|
5.91
+3.4
YoY
|
-
No YoY
|
|
|
12.78M
|
Composite
50.1
Moat
41.9
|
6.80
-15.2
YoY
|
-13.1%
+32.0
YoY
|
|
|
12.54M
|
Composite
57.2
Moat
43.5
|
10.57
+9.2
YoY
|
-132.2%
No YoY
|
|
|
12.24M
|
Composite
31.2
Moat
15.4
|
4.75
-6.9
YoY
|
-56.5%
+26.1
YoY
|
|
|
FEMY
Femasys Inc.
|
12.20M
|
Composite
31.2
Moat
43.1
|
5.95
+3.8
YoY
|
-7.7%
+3.2
YoY
|
|
12.20M
|
Composite
51.7
Moat
64.1
|
31.63
+22.5
YoY
|
-
No YoY
|
|
|
CALC
CalciMedica, Inc.
|
11.93M
|
Composite
37.0
Moat
23.0
|
7.38
-3.2
YoY
|
-
No YoY
|
|
AKAN
Akanda Corp.
|
11.84M
|
Composite
24.0
Moat
16.9
|
0.90
-10.7
YoY
|
-19.3%
-14.1
YoY
|
|
TRIB
Trinity Biotech plc
|
11.75M
|
Composite
33.4
Moat
46.2
|
10.40
-4.4
YoY
|
-26.1%
-0.9
YoY
|
|
RENB
Renovaro Inc.
|
11.60M
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
11.60M
|
Composite
46.7
Moat
33.2
|
9.40
+1.2
YoY
|
-
No YoY
|
|
|
COSM
Cosmos Health Inc.
|
11.48M
|
Composite
30.8
Moat
21.3
|
1.08
+0.6
YoY
|
-25.3%
+2.7
YoY
|
|
CODX
Co-Diagnostics, Inc.
|
11.20M
|
Composite
38.6
Moat
25.9
|
4.89
-7.3
YoY
|
-50.3%
-40.0
YoY
|
|
VNRX
VolitionRX Limited
|
11.20M
|
Composite
35.5
Moat
60.5
|
0.68
-0.8
YoY
|
-12.3%
+9.5
YoY
|
|
GELS
Gelteq Limited
|
11.14M
|
Composite
36.9
Moat
17.5
|
0.75
+0.5
YoY
|
-29.9%
+12.4
YoY
|
|
BCDA
BioCardia, Inc.
|
11.00M
|
Composite
38.5
Moat
13.0
|
4.03
+0.5
YoY
|
-137.9%
-113.5
YoY
|
|
10.90M
|
Composite
52.5
Moat
69.3
|
20.59
+17.5
YoY
|
34.9%
No YoY
|
|
|
10.87M
|
Composite
44.6
Moat
39.8
|
11.18
+0.0
YoY
|
-
No YoY
|
|
|
10.64M
|
Composite
49.0
Moat
33.3
|
15.49
+13.5
YoY
|
-
No YoY
|
|
|
10.40M
|
Composite
41.0
Moat
28.9
|
3.28
-12.4
YoY
|
-43.5%
-14.7
YoY
|
|
|
9.99M
|
Composite
40.2
Moat
19.0
|
8.40
-3.2
YoY
|
-408.7%
-394.0
YoY
|
|
|
9.83M
|
Composite
52.4
Moat
37.0
|
13.59
-6.6
YoY
|
-
No YoY
|
|
|
9.70M
|
Composite
38.4
Moat
52.5
|
-
No YoY
|
-7.2%
-13.4
YoY
|
|
|
XWEL
XWELL, Inc.
|
9.60M
|
Composite
30.7
Moat
34.3
|
3.61
-9.2
YoY
|
-32.0%
+3.7
YoY
|
|
9.53M
|
Composite
43.5
Moat
67.9
|
0.46
-4.6
YoY
|
-
No YoY
|
|
|
IMRN
Immuron Limited
|
9.40M
|
Composite
49.0
Moat
55.1
|
5.53
-86.1
YoY
|
-73.5%
-72.4
YoY
|
|
9.34M
|
Composite
47.4
Moat
35.0
|
16.61
-4.9
YoY
|
-
No YoY
|
|
|
KAPA
Kairos Pharma, Ltd.
|
9.23M
|
Composite
58.3
Moat
40.3
|
15.66
+11.8
YoY
|
-
No YoY
|
|
9.15M
|
Composite
47.0
Moat
15.7
|
7.04
+2.2
YoY
|
-
No YoY
|
|
|
9.12M
|
Composite
36.8
Moat
17.6
|
3.82
-12.5
YoY
|
-
No YoY
|
|
|
9.10M
|
Composite
33.8
Moat
12.8
|
5.80
+0.8
YoY
|
-14.7%
-7.5
YoY
|
|
|
8.61M
|
Composite
50.9
Moat
51.0
|
0.05
-0.2
YoY
|
-
No YoY
|
|
|
8.39M
|
Composite
43.1
Moat
38.6
|
3.34
+0.1
YoY
|
-132.5%
-16.2
YoY
|
|
|
HCWB
HCW Biologics Inc.
|
8.31M
|
Composite
43.4
Moat
28.4
|
1.75
-2.2
YoY
|
-207.6%
-196.3
YoY
|
|
8.25M
|
Composite
41.2
Moat
40.0
|
18.85
No YoY
|
1.0%
-9.0
YoY
|
|
|
8.20M
|
Composite
60.6
Moat
75.2
|
62.61
-217.3
YoY
|
-
No YoY
|
|
|
SYBX
Synlogic, Inc.
|
8.19M
|
Composite
44.0
Moat
23.3
|
40.38
+33.2
YoY
|
-1972.1%
-1955.8
YoY
|
|
8.17M
|
Composite
37.8
Moat
32.5
|
9.09
+1.6
YoY
|
-93.9%
-87.1
YoY
|
|
|
MTVA
MetaVia Inc.
|
8.11M
|
Composite
49.4
Moat
36.4
|
7.86
+0.1
YoY
|
-
No YoY
|
|
7.71M
|
Composite
46.8
Moat
42.1
|
8.28
-1.0
YoY
|
-4.5%
+4.4
YoY
|
|
|
7.66M
|
Composite
37.7
Moat
41.7
|
9.01
-1.6
YoY
|
-27.8%
+18.1
YoY
|
|
|
IMNN
Imunon, Inc.
|
7.60M
|
Composite
48.1
Moat
37.1
|
7.58
+3.8
YoY
|
-49.8%
-7.8
YoY
|
|
NCNA
NuCana plc
|
7.60M
|
Composite
56.1
Moat
39.9
|
38.97
+34.7
YoY
|
-
No YoY
|
|
ACON
Aclarion, Inc.
|
7.49M
|
Composite
35.6
Moat
11.2
|
20.13
+19.1
YoY
|
-93.1%
+27.4
YoY
|
|
7.29M
|
Composite
58.5
Moat
63.1
|
0.69
-5.9
YoY
|
11.6%
No YoY
|
|
|
YCBD
cbdMD, Inc.
|
7.24M
|
Composite
54.8
Moat
39.6
|
18.68
-64.7
YoY
|
-11.3%
+5.8
YoY
|
|
7.11M
|
Composite
40.4
Moat
59.3
|
19.72
+16.7
YoY
|
-
No YoY
|
|
|
7.10M
|
Composite
42.6
Moat
26.5
|
14.77
+1.3
YoY
|
-1023.8%
-501.6
YoY
|
|
|
6.99M
|
Composite
49.9
Moat
43.7
|
22.56
+13.7
YoY
|
-24.6%
-11.3
YoY
|
|
|
6.87M
|
Composite
39.1
Moat
22.4
|
3.22
+1.9
YoY
|
-29.6%
+274.4
YoY
|
|
|
6.77M
|
Composite
37.9
Moat
23.7
|
0.83
+0.2
YoY
|
-2.3%
+19.1
YoY
|
|
|
6.70M
|
Composite
37.0
Moat
35.6
|
21.75
-9.0
YoY
|
-
No YoY
|
|
|
6.70M
|
Composite
61.4
Moat
70.3
|
41.37
+15.1
YoY
|
-95.2%
-93.5
YoY
|
|
|
6.70M
|
Composite
49.0
Moat
25.7
|
17.11
+5.8
YoY
|
-1.6%
+0.2
YoY
|
|
|
6.58M
|
Composite
26.5
Moat
13.8
|
1.77
-3.5
YoY
|
-
No YoY
|
|
|
6.55M
|
Composite
41.4
Moat
42.7
|
11.45
-0.9
YoY
|
-24.6%
-12.5
YoY
|
|
|
6.46M
|
Composite
53.4
Moat
11.0
|
13.36
+9.1
YoY
|
-
No YoY
|
|
|
6.41M
|
Composite
27.9
Moat
16.1
|
2.61
-9.2
YoY
|
-
No YoY
|
|
|
NXTC
NextCure, Inc.
|
6.32M
|
Composite
49.2
Moat
43.5
|
10.11
-10.1
YoY
|
-
No YoY
|
|
PPBT
Purple Biotech Ltd.
|
6.27M
|
Composite
45.1
Moat
39.4
|
20.31
+13.2
YoY
|
-
No YoY
|
|
6.26M
|
Composite
41.0
Moat
14.5
|
6.26
+1.7
YoY
|
-
No YoY
|
|
|
ELAB
PMGC Holdings Inc.
|
6.13M
|
Composite
48.5
Moat
37.9
|
12.08
+3.4
YoY
|
-11.6%
-9.2
YoY
|
|
PTHL
Pheton Holdings Ltd
|
6.01M
|
Composite
42.7
Moat
40.7
|
95.38
+54.3
YoY
|
-1.5%
+39.7
YoY
|
|
BCAB
BioAtla, Inc.
|
6.00M
|
Composite
43.2
Moat
41.7
|
1.77
-6.4
YoY
|
-29.7%
-22.9
YoY
|
|
5.90M
|
Composite
46.9
Moat
49.3
|
10.14
+5.7
YoY
|
-9.2%
-7.5
YoY
|
|
|
5.83M
|
Composite
43.9
Moat
33.4
|
10.71
-8.1
YoY
|
-437.4%
-197.6
YoY
|
|
|
5.81M
|
Composite
40.2
Moat
35.6
|
10.87
+4.4
YoY
|
-
No YoY
|
|
|
GNPX
Genprex, Inc.
|
5.80M
|
Composite
37.7
Moat
31.3
|
6.14
+5.0
YoY
|
-
No YoY
|
|
5.80M
|
Composite
49.1
Moat
21.3
|
5.84
+4.6
YoY
|
-
No YoY
|
|
|
SNGX
Soligenix, Inc.
|
5.80M
|
Composite
43.5
Moat
18.7
|
9.28
-1.9
YoY
|
-56.4%
+331.1
YoY
|
|
5.72M
|
Composite
60.2
Moat
49.1
|
8.48
-25.6
YoY
|
-4.8%
No YoY
|
|
|
BMRA
Biomerica, Inc.
|
5.70M
|
Composite
41.4
Moat
35.7
|
7.49
-1.8
YoY
|
-96.7%
-95.5
YoY
|
|
5.69M
|
Composite
37.3
Moat
29.8
|
1.26
-6.6
YoY
|
-3.4%
-0.1
YoY
|
|
|
HSCS
HeartSciences Inc.
|
5.64M
|
Composite
38.2
Moat
16.6
|
1.78
-9.7
YoY
|
-1920.1%
-1581.1
YoY
|
|
PULM
Pulmatrix, Inc.
|
5.62M
|
Composite
44.9
Moat
55.5
|
9.03
-1.6
YoY
|
-91.5%
-89.5
YoY
|
|
VSEE
VSee Health, Inc.
|
5.62M
|
Composite
30.7
Moat
22.3
|
0.68
-1.6
YoY
|
-6.0%
+39.0
YoY
|
|
5.59M
|
Composite
32.9
Moat
34.9
|
1.60
-4.3
YoY
|
-1.1%
+73.2
YoY
|
|
|
5.55M
|
Composite
46.9
Moat
36.6
|
732.8
+717.2
YoY
|
-26.0%
+10.9
YoY
|
|
|
EVGN
Evogene Ltd.
|
5.52M
|
Composite
52.0
Moat
52.6
|
11.51
+2.2
YoY
|
-3.6%
-1.0
YoY
|
|
XAIR
Beyond Air, Inc.
|
5.40M
|
Composite
40.4
Moat
17.1
|
2.17
-5.2
YoY
|
-12.0%
+42.3
YoY
|
|
NXGL
NexGel, Inc
|
5.18M
|
Composite
33.5
Moat
39.0
|
2.90
-2.7
YoY
|
-29.3%
+11.6
YoY
|
|
5.10M
|
Composite
46.1
Moat
16.2
|
5.79
+3.2
YoY
|
-845.0%
-363.8
YoY
|
|
|
MGRX
Mangoceuticals, Inc.
|
5.00M
|
Composite
32.1
Moat
19.3
|
3.05
+2.9
YoY
|
-42.0%
-27.9
YoY
|
|
4.95M
|
Composite
51.8
Moat
30.3
|
11.64
+8.2
YoY
|
-
No YoY
|
|
|
4.90M
|
Composite
48.5
Moat
38.7
|
7.12
-3.0
YoY
|
-4.8%
+28.7
YoY
|
|
|
MBIO
Mustang Bio, Inc.
|
4.90M
|
Composite
54.1
Moat
30.9
|
39.36
+32.2
YoY
|
-
No YoY
|
|
4.90M
|
Composite
42.5
Moat
31.8
|
6.89
+3.4
YoY
|
-
No YoY
|
|
|
4.75M
|
Composite
42.7
Moat
26.1
|
10.95
+5.7
YoY
|
-
No YoY
|
|
|
ALZN
Alzamend Neuro, Inc.
|
4.64M
|
Composite
54.9
Moat
21.5
|
7.21
+6.7
YoY
|
-
No YoY
|
|
GOVX
GeoVax Labs, Inc.
|
4.58M
|
Composite
39.0
Moat
38.6
|
1.72
-1.0
YoY
|
-8.7%
-2.3
YoY
|
|
PHGE
BiomX Inc.
|
4.57M
|
Composite
42.6
Moat
23.1
|
1.98
-3.5
YoY
|
-
No YoY
|
|
4.44M
|
Composite
29.4
Moat
30.0
|
5.54
+5.3
YoY
|
-70.3%
-31.2
YoY
|
|
|
4.43M
|
Composite
41.5
Moat
16.5
|
14.16
+2.0
YoY
|
-
No YoY
|
|
|
4.36M
|
Composite
48.0
Moat
40.0
|
2.65
-0.9
YoY
|
-7.7%
+8.3
YoY
|
|
|
4.35M
|
Composite
45.6
Moat
49.6
|
6.61
-11.9
YoY
|
-1.4%
+73.2
YoY
|
|
|
FBLG
FibroBiologics, Inc.
|
4.35M
|
Composite
49.8
Moat
15.2
|
14.10
-3.1
YoY
|
-
No YoY
|
|
4.29M
|
Composite
45.0
Moat
14.0
|
0.85
-2.5
YoY
|
-
No YoY
|
|
|
MYNZ
Mainz Biomed N.V.
|
4.28M
|
Composite
27.6
Moat
35.9
|
4.38
+0.5
YoY
|
-20.6%
+9.2
YoY
|
|
4.19M
|
Composite
32.9
Moat
18.9
|
12.57
+0.7
YoY
|
-46.4%
-45.2
YoY
|
|
|
4.17M
|
Composite
49.5
Moat
52.3
|
10.81
+3.5
YoY
|
-
No YoY
|
|
|
4.16M
|
Composite
40.5
Moat
21.5
|
13.28
-2.3
YoY
|
-
No YoY
|
|
|
4.10M
|
Composite
39.9
Moat
25.8
|
15.53
+11.3
YoY
|
-
No YoY
|
|
|
4.10M
|
Composite
33.8
Moat
17.3
|
4.94
-1.0
YoY
|
-27.7%
-26.1
YoY
|
|
|
TNON
Tenon Medical, Inc.
|
4.05M
|
Composite
38.2
Moat
32.8
|
4.19
-3.7
YoY
|
-3.2%
+1.0
YoY
|
|
4.01M
|
Composite
43.1
Moat
15.3
|
6.63
+1.0
YoY
|
-
No YoY
|
|
|
4.00M
|
Composite
46.8
Moat
41.8
|
6.84
+1.3
YoY
|
-21.7%
-14.0
YoY
|
|
|
SPRC
SciSparc Ltd.
|
4.00M
|
Composite
38.4
Moat
44.8
|
13.32
+8.5
YoY
|
-10.2%
-4.7
YoY
|
|
3.99M
|
Composite
33.8
Moat
15.7
|
10.24
+3.6
YoY
|
-37.4%
No YoY
|
|
|
AZTR
Azitra Inc
|
3.72M
|
Composite
31.3
Moat
21.8
|
2.21
-3.2
YoY
|
-1464.7%
-1453.8
YoY
|
|
3.72M
|
Composite
57.0
Moat
33.5
|
6.46
+0.9
YoY
|
-
No YoY
|
|
|
3.70M
|
Composite
60.2
Moat
45.9
|
34.50
+3.2
YoY
|
-
No YoY
|
|
|
3.67M
|
Composite
26.2
Moat
27.3
|
8.30
+6.5
YoY
|
-1.7%
+93.9
YoY
|
|
|
ISPC
iSpecimen Inc.
|
3.62M
|
Composite
27.6
Moat
13.3
|
19.47
+16.7
YoY
|
-4.7%
-3.3
YoY
|
|
ONCO
Onconetix, Inc.
|
3.50M
|
Composite
45.7
Moat
40.8
|
6.47
+5.7
YoY
|
-7.8%
-3.7
YoY
|
|
GRI
GRI Bio, Inc.
|
3.33M
|
Composite
46.5
Moat
16.0
|
9.69
+2.7
YoY
|
-
No YoY
|
|
3.31M
|
Composite
38.8
Moat
30.6
|
20.54
+11.3
YoY
|
-12.3%
+4.3
YoY
|
|
|
3.30M
|
Composite
38.5
Moat
40.4
|
8.63
+2.2
YoY
|
-20.7%
+14.7
YoY
|
|
|
SNYR
Synergy CHC Corp.
|
3.30M
|
Composite
28.7
Moat
41.3
|
12.17
+10.5
YoY
|
-5.9%
-22.6
YoY
|
|
3.29M
|
Composite
42.9
Moat
14.5
|
3.16
-2.7
YoY
|
-514.0%
-490.6
YoY
|
|
|
3.25M
|
Composite
42.9
Moat
15.7
|
11.12
+4.2
YoY
|
-973.4%
-931.9
YoY
|
|
|
VCNX
Vaccinex, Inc.
|
2.81M
|
Composite
37.0
Moat
36.0
|
0.82
-0.0
YoY
|
-31.2%
+9.0
YoY
|
|
OGEN
Oragenics Inc.
|
2.60M
|
Composite
55.9
Moat
37.0
|
10.90
+9.7
YoY
|
-
No YoY
|
|
BBLG
Bone Biologics Corp
|
2.46M
|
Composite
50.0
Moat
25.2
|
23.79
+14.1
YoY
|
-
No YoY
|
|
GCTK
GlucoTrack, Inc.
|
2.31M
|
Composite
29.5
Moat
23.2
|
5.81
+0.4
YoY
|
-
No YoY
|
|
SYRA
Syra Health Corp.
|
2.27M
|
Composite
26.6
Moat
25.7
|
43.28
+33.5
YoY
|
-12.5%
+34.7
YoY
|
|
2.26M
|
Composite
31.2
Moat
43.3
|
0.13
-3.6
YoY
|
-14.9%
+11.9
YoY
|
|
|
2.25M
|
Composite
43.1
Moat
34.0
|
18.32
+16.7
YoY
|
-21.0%
-8.3
YoY
|
|
|
2.15M
|
Composite
51.2
Moat
46.8
|
9.73
-9.4
YoY
|
-17.4%
-14.3
YoY
|
|
|
2.06M
|
Composite
30.9
Moat
4.7
|
0.42
-2.7
YoY
|
-
No YoY
|
|
|
1.86M
|
Composite
46.6
Moat
36.9
|
79.79
+42.6
YoY
|
-16.3%
+18.5
YoY
|
|
|
1.64M
|
Composite
37.8
Moat
15.0
|
21.68
+17.5
YoY
|
-7.3%
-0.2
YoY
|
|
|
1.62M
|
Composite
43.9
Moat
53.5
|
0.24
-2.2
YoY
|
-
No YoY
|
|
|
JAGX
Jaguar Health, Inc.
|
1.57M
|
Composite
38.4
Moat
46.9
|
0.49
-2.8
YoY
|
-3.9%
-1.3
YoY
|
|
1.42M
|
Composite
44.8
Moat
45.0
|
33.98
-122.9
YoY
|
-19.0%
-2.9
YoY
|
|
|
PRFX
PainReform Ltd.
|
1.39M
|
Composite
33.6
Moat
8.6
|
12.56
+8.5
YoY
|
-301.3%
No YoY
|
|
1.28M
|
Composite
44.0
Moat
25.3
|
5.23
-7.9
YoY
|
-
No YoY
|
|
|
1.15M
|
Composite
50.0
Moat
34.8
|
3.30
-0.4
YoY
|
-5.8%
+7.4
YoY
|
|
|
1.13M
|
Composite
44.4
Moat
34.2
|
6.64
+4.9
YoY
|
-
No YoY
|
|
|
IMCC
IM Cannabis Corp.
|
1.10M
|
Composite
39.9
Moat
30.3
|
9.62
+6.9
YoY
|
-21.2%
-2.2
YoY
|
|
1.05M
|
Composite
50.6
Moat
49.2
|
18.69
+15.2
YoY
|
-2.3%
No YoY
|
|
|
1.01M
|
Composite
44.4
Moat
36.9
|
6.61
-0.3
YoY
|
-74.3%
-34.7
YoY
|
|
|
891,300
|
Composite
55.4
Moat
49.5
|
3.59
-7.9
YoY
|
-3.2%
+2.8
YoY
|
|
|
LGMK
LogicMark, Inc.
|
674,819
|
Composite
37.1
Moat
32.2
|
22.55
+11.8
YoY
|
-69.1%
+8.3
YoY
|
|
631,573
|
Composite
44.6
Moat
61.2
|
1.24
-2.1
YoY
|
-
No YoY
|
|
|
NOTV
Inotiv, Inc.
|
608,798
|
Composite
41.7
Moat
38.2
|
24.95
-12.8
YoY
|
-7.2%
+3.9
YoY
|
|
VERO
Venus Concept Inc.
|
563,314
|
Composite
32.7
Moat
50.3
|
4.63
-0.4
YoY
|
-41.9%
-4.9
YoY
|
|
516,620
|
Composite
42.8
Moat
7.7
|
1.33
+0.2
YoY
|
-
No YoY
|
|
|
497,436
|
Composite
50.0
Moat
41.4
|
3.75
-4.3
YoY
|
-
No YoY
|
|
|
IOBT
IO Biotech, Inc.
|
467,667
|
Composite
51.4
Moat
33.1
|
8.75
-15.2
YoY
|
-
No YoY
|
|
441,572
|
Composite
40.7
Moat
20.2
|
6.71
+6.4
YoY
|
-
No YoY
|
|
|
MSPR
MSP Recovery, Inc.
|
399,683
|
Composite
27.6
Moat
14.4
|
9.18
+5.7
YoY
|
-28.6%
+44.1
YoY
|
|
NUWE
Nuwellis, Inc.
|
382,466
|
Composite
30.2
Moat
43.2
|
1.20
-5.2
YoY
|
-1.3%
-0.1
YoY
|
|
373,266
|
Composite
38.6
Moat
25.6
|
0.64
+0.4
YoY
|
-21.4%
-19.9
YoY
|
|
|
WORX
SCWorx Corp.
|
341,414
|
Composite
29.1
Moat
34.3
|
12.78
+11.6
YoY
|
-33.3%
+8.8
YoY
|
|
337,087
|
Composite
37.8
Moat
41.2
|
1.39
-2.5
YoY
|
-
No YoY
|
|
|
PRPH
ProPhase Labs, Inc.
|
331,590
|
Composite
26.7
Moat
17.9
|
0.13
-0.3
YoY
|
-4.2%
+1.6
YoY
|
|
254,233
|
Composite
36.0
Moat
31.6
|
9.15
-8.0
YoY
|
-2.0%
-0.2
YoY
|
|
|
191,166
|
Composite
38.6
Moat
8.5
|
0.05
-2.1
YoY
|
-
No YoY
|
|
|
BACK
IMAC Holdings, Inc.
|
174,108
|
Composite
23.4
Moat
20.1
|
1.91
+1.0
YoY
|
-78.0%
-8.9
YoY
|
|
161,729
|
Composite
50.5
Moat
34.4
|
6.64
-5.9
YoY
|
-9.5%
+1.1
YoY
|
|
|
ZCMD
Zhongchao Inc.
|
80,601
|
Composite
42.0
Moat
40.9
|
106.6
-111.7
YoY
|
-54.4%
-52.3
YoY
|
|
69,709
|
Composite
37.4
Moat
61.9
|
0.00
-0.0
YoY
|
-
No YoY
|
|
|
VINC
Vincerx Pharma, Inc.
|
65,428
|
Composite
42.8
Moat
16.4
|
2.29
-1.5
YoY
|
-
No YoY
|
|
DHAI
DIH Holding US, Inc.
|
62,779
|
Composite
45.5
Moat
48.2
|
0.21
-1.9
YoY
|
-7.7%
-3.7
YoY
|
|
37,207
|
Composite
54.1
Moat
53.8
|
35.32
+31.4
YoY
|
-9.1%
+23.1
YoY
|
|
|
ADTX
Aditxt, Inc.
|
15,666
|
Composite
34.6
Moat
11.8
|
1.49
+0.9
YoY
|
-6125.4%
-5917.5
YoY
|
|
12,074
|
Composite
46.2
Moat
38.1
|
15.26
-4.5
YoY
|
-12.7%
-4.2
YoY
|
|
|
TTOO
T2 Biosystems, Inc.
|
11,218
|
Composite
26.5
Moat
19.6
|
3.91
+1.5
YoY
|
-6.6%
-4.1
YoY
|
|
ICCT
iCoreConnect Inc.
|
2,438
|
Composite
30.9
Moat
30.9
|
0.75
-0.9
YoY
|
-1.4%
-0.2
YoY
|
|
941
|
Composite
37.6
Moat
42.9
|
7.46
-4.7
YoY
|
-
No YoY
|
|
|
OTRK
Ontrak, Inc.
|
708
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
621
|
Composite
37.0
Moat
32.3
|
1.09
-10.0
YoY
|
-
No YoY
|
|
|
-
|
Composite
61.3
Moat
78.0
|
3.10
-1.9
YoY
|
16.2%
+26.0
YoY
|
|
|
ABPWW
Abpro Holdings, Inc.
|
-
|
Composite
40.2
Moat
47.1
|
0.13
-3.7
YoY
|
-54.2%
+42.1
YoY
|
|
ACCD
Accolade, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
58.7
Moat
69.5
|
-
No YoY
|
-
No YoY
|
|
|
ACONW
Aclarion, Inc.
|
-
|
Composite
37.6
Moat
11.2
|
20.13
+19.1
YoY
|
-93.1%
+27.4
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
53.7
Moat
30.8
|
-
No YoY
|
-139.2%
-103.3
YoY
|
|
|
AFMD
Affimed N.V.
|
-
|
Composite
42.5
Moat
49.2
|
-
No YoY
|
-12.9%
-10.8
YoY
|
|
-
|
Composite
33.9
Moat
33.3
|
1.09
-7.0
YoY
|
-112.7%
+555.0
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
ALLK
Allakos Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
ALVOW
Alvotech Warrant
|
-
|
Composite
54.2
Moat
49.0
|
41.20
+38.6
YoY
|
13.3%
-0.9
YoY
|
|
ALVR
AlloVir, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
AMED
Amedisys Inc
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
47.0
Moat
39.5
|
176.3
+134.0
YoY
|
-0.9%
+0.5
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
48.0
Moat
13.8
|
11.30
+0.4
YoY
|
-229.2%
-222.8
YoY
|
|
|
-
|
Composite
44.8
Moat
36.3
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
ATNFW
180 Life Sciences Corp.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
66.8
Moat
31.5
|
18.87
+9.1
YoY
|
-25.1%
-20.1
YoY
|
|
|
AVGR
Avinger, Inc.
|
-
|
Composite
26.0
Moat
30.8
|
-
No YoY
|
-2.2%
-0.2
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
28.2
Moat
41.8
|
-
No YoY
|
-3.0%
+1.5
YoY
|
|
|
-
|
Composite
46.1
Moat
25.2
|
23.79
+14.1
YoY
|
-
No YoY
|
|
|
-
|
Composite
46.3
Moat
39.3
|
0.43
-10.3
YoY
|
-
No YoY
|
|
|
-
|
Composite
44.6
Moat
46.1
|
1.59
-4.1
YoY
|
-1.1%
-42.5
YoY
|
|
|
-
|
Composite
40.0
Moat
37.9
|
5.75
-1.2
YoY
|
-27.2%
+18.9
YoY
|
|
|
BGNE
BeiGene, Ltd.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
28.9
Moat
27.3
|
8.30
+6.5
YoY
|
-1.7%
+93.9
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
BLUE
bluebird bio, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
64.7
Moat
46.1
|
35.15
No YoY
|
1.8%
+0.2
YoY
|
|
|
CANB
CAN B CORP.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
67.7
Moat
68.2
|
-
No YoY
|
9.5%
+0.8
YoY
|
|
|
-
|
Composite
56.7
Moat
63.4
|
-
No YoY
|
8.2%
+48.5
YoY
|
|
|
-
|
Composite
39.6
Moat
32.6
|
10.71
-8.1
YoY
|
-437.4%
-197.6
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
39.1
Moat
59.2
|
1.16
+0.5
YoY
|
-
No YoY
|
|
|
-
|
Composite
45.5
Moat
30.9
|
12.90
-6.2
YoY
|
-138.1%
-137.0
YoY
|
|
|
CELUW
Celularity Inc.
|
-
|
Composite
44.8
Moat
57.5
|
5.59
+4.2
YoY
|
-2.3%
+68.8
YoY
|
|
-
|
Composite
40.8
Moat
61.2
|
1.24
-2.1
YoY
|
-
No YoY
|
|
|
CHEK
Check-Cap Ltd.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
CINGW
Cingulate Inc. Warrants
|
-
|
Composite
47.0
Moat
14.3
|
7.62
-0.3
YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
CMRX
Chimerix, Inc.
|
-
|
Composite
46.9
Moat
27.4
|
-
No YoY
|
-455.5%
-168.3
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
CUTR
Cutera, Inc.
|
-
|
Composite
33.9
Moat
27.1
|
-
No YoY
|
-73.6%
-58.4
YoY
|
|
CYBN
Cybin Inc.
|
-
|
Composite
56.6
Moat
60.2
|
15.99
-20.4
YoY
|
-
No YoY
|
|
-
|
Composite
56.0
Moat
38.0
|
-
No YoY
|
-279.2%
-218.6
YoY
|
|
|
-
|
Composite
44.0
Moat
38.0
|
-
No YoY
|
-279.2%
-218.6
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
CYTHW
Cyclo Therapeutics, Inc.
|
-
|
Composite
29.7
Moat
21.5
|
-
No YoY
|
-18.6%
0.0
YoY
|
|
-
|
Composite
44.0
Moat
57.5
|
-
No YoY
|
-4.0%
-3.6
YoY
|
|
|
-
|
Composite
42.6
Moat
20.2
|
11.64
+8.2
YoY
|
-
No YoY
|
|
|
DRRX
DURECT Corporation
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
52.8
Moat
45.5
|
32.89
-3.3
YoY
|
-
No YoY
|
|
|
-
|
Composite
68.1
Moat
57.1
|
-
No YoY
|
-1.5%
+9.6
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
56.0
Moat
42.6
|
23.43
-35.8
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
EPIX
ESSA Pharma Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
41.6
Moat
17.0
|
3.11
-19.2
YoY
|
-
No YoY
|
|
|
ETNB
89bio, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
38.7
Moat
34.8
|
1.71
+0.3
YoY
|
-35.8%
+28.5
YoY
|
|
|
EVOK
Evoke Pharma, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
EYEN
Eyenovia, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
FNA
Paragon 28, Inc.
|
-
|
Composite
51.7
Moat
64.1
|
-
No YoY
|
-15.9%
+1.3
YoY
|
|
GBIO
Generation Bio Co.
|
-
|
Composite
54.1
Moat
57.3
|
25.10
-35.0
YoY
|
-4.0%
+19.5
YoY
|
|
-
|
Composite
21.8
Moat
25.9
|
-
No YoY
|
-85.3%
-84.3
YoY
|
|
|
GLYC
GlycoMimetics, Inc.
|
-
|
Composite
45.6
Moat
28.4
|
-
No YoY
|
-3927.5%
-3294.9
YoY
|
|
GNFT
GENFIT S.A.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
GOVXW
GeoVax Labs, Inc.
|
-
|
Composite
39.7
Moat
34.6
|
1.72
-1.0
YoY
|
-8.7%
-2.3
YoY
|
|
HLVX
HilleVax, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
36.5
Moat
16.7
|
1.78
-9.7
YoY
|
-1920.1%
-1581.1
YoY
|
|
|
HUMAW
Humacyte, Inc.
|
-
|
Composite
42.1
Moat
32.1
|
5.77
+0.3
YoY
|
-53.1%
No YoY
|
|
ICAD
icad inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
31.1
Moat
9.5
|
3.84
-3.6
YoY
|
-47.1%
No YoY
|
|
|
IKNA
Ikena Oncology, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
IMAB
I-MAB
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
IMTXW
Immatics N.V.
|
-
|
Composite
47.9
Moat
55.1
|
31.89
-14.0
YoY
|
-3.8%
+21.0
YoY
|
|
INZY
Inozyme Pharma, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
43.4
Moat
47.5
|
4.46
-9.3
YoY
|
-
No YoY
|
|
|
KDLY
Kindly MD, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
KDLYW
Kindly MD, Inc. Warrants
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
53.7
Moat
22.6
|
0.26
+0.2
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
KRON
Kronos Bio, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
51.1
Moat
45.6
|
43.51
+37.5
YoY
|
-299.3%
No YoY
|
|
|
LEXXW
Lexaria Bioscience Corp.
|
-
|
Composite
44.1
Moat
42.6
|
2.26
-13.6
YoY
|
-16.8%
-4.4
YoY
|
|
-
|
Composite
53.9
Moat
42.5
|
2.07
-12.9
YoY
|
-4.0%
+3.6
YoY
|
|
|
-
|
Composite
40.8
Moat
39.1
|
19.96
+16.0
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
58.9
Moat
69.9
|
-
No YoY
|
-14.0%
+63.7
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
41.3
Moat
34.8
|
-
No YoY
|
-1.5%
-0.4
YoY
|
|
|
-
|
Composite
44.1
Moat
60.8
|
-
No YoY
|
14.8%
-0.3
YoY
|
|
|
-
|
Composite
46.2
Moat
64.9
|
0.83
-6.1
YoY
|
-1.1%
-10.0
YoY
|
|
|
MODV
ModivCare Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
MRUS
Merus N.V.
|
-
|
Composite
54.2
Moat
55.2
|
34.68
+4.8
YoY
|
-7.5%
-4.0
YoY
|
|
MSPRW
MSP Recovery, Inc.
|
-
|
Composite
28.2
Moat
14.3
|
9.18
+5.7
YoY
|
-28.6%
+44.1
YoY
|
|
MSPRZ
MSP Recovery, Inc.
|
-
|
Composite
28.2
Moat
14.3
|
9.18
+5.7
YoY
|
-28.6%
+44.1
YoY
|
|
MURA
Mural Oncology plc
|
-
|
Composite
51.1
Moat
67.7
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
45.0
Moat
49.1
|
51.66
-11.5
YoY
|
-10.0%
-6.2
YoY
|
|
|
NAOV
NanoVibronix, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
NARI
Inari Medical, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
NEUE
NeueHealth, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
48.1
Moat
23.7
|
0.83
+0.2
YoY
|
-2.3%
+19.1
YoY
|
|
|
-
|
Composite
41.8
Moat
26.5
|
0.01
-0.0
YoY
|
-316.2%
-264.9
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
NLSPW
NLS Pharmaceutics Ltd.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
33.7
Moat
36.5
|
0.26
-3.7
YoY
|
-
No YoY
|
|
|
-
|
Composite
42.3
Moat
43.0
|
6.63
+5.0
YoY
|
-13.2%
No YoY
|
|
|
NTRBW
Nutriband Inc. Warrant
|
-
|
Composite
43.5
Moat
46.4
|
11.18
+9.5
YoY
|
-3.1%
-0.8
YoY
|
|
NURO
NeuroMetrix, Inc.
|
-
|
Composite
36.4
Moat
31.1
|
-
No YoY
|
-2.9%
-1.7
YoY
|
|
NVRO
Nevro Corp.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
NXGLW
NexGel, Inc Warrant
|
-
|
Composite
34.4
Moat
39.0
|
2.90
-2.7
YoY
|
-29.3%
+11.6
YoY
|
|
NXLIW
Nexalin Technology, Inc.
|
-
|
Composite
36.9
Moat
42.3
|
9.01
-1.6
YoY
|
-27.8%
+18.1
YoY
|
|
OABIW
OmniAb, Inc.
|
-
|
Composite
54.1
Moat
66.5
|
17.78
-0.2
YoY
|
-3.7%
-0.9
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
33.7
Moat
45.7
|
-
No YoY
|
2.8%
-0.2
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
46.2
Moat
28.5
|
-
No YoY
|
-53.1%
-23.0
YoY
|
|
|
ONMDW
OneMedNet Corporation
|
-
|
Composite
31.2
Moat
17.8
|
1.74
-3.4
YoY
|
-7.1%
+7.8
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
OPT
Opthea Limited
|
-
|
Composite
33.7
Moat
21.9
|
-
No YoY
|
-1538.9%
-152.4
YoY
|
|
OPTN
OptiNose, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
OTRKP
Ontrak, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
PAVMZ
PAVmed Inc. - Series Z
|
-
|
Composite
37.2
Moat
14.3
|
3.55
+3.1
YoY
|
-301.3%
-286.5
YoY
|
|
-
|
Composite
42.6
Moat
58.9
|
19.72
+16.7
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
PIIIW
P3 Health Partners Inc.
|
-
|
Composite
19.6
Moat
33.8
|
3.29
-0.9
YoY
|
-18.5%
+2.3
YoY
|
|
PINC
Premier, Inc.
|
-
|
Composite
52.7
Moat
55.3
|
-
No YoY
|
0.1%
-11.0
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
PRENW
Prenetics Global Limited
|
-
|
Composite
38.9
Moat
42.9
|
34.82
+8.7
YoY
|
-41.3%
-39.6
YoY
|
|
PROC
Procaps Group, S.A.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
PRTG
Portage Biotech Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
43.0
Moat
26.3
|
5.23
-7.9
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
QSIAW
Quantum-Si incorporated
|
-
|
Composite
38.9
Moat
46.2
|
20.64
-8.0
YoY
|
-40.0%
-4.5
YoY
|
|
-
|
Composite
43.4
Moat
25.9
|
15.53
+11.3
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
44.1
Moat
45.3
|
27.08
-22.2
YoY
|
-42.1%
-34.8
YoY
|
|
|
-
|
Composite
50.7
Moat
52.7
|
-
No YoY
|
-1.4%
+0.7
YoY
|
|
|
-
|
Composite
36.5
Moat
16.0
|
7.04
+2.2
YoY
|
-
No YoY
|
|
|
-
|
Composite
55.9
Moat
76.1
|
25.89
+18.6
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
47.9
Moat
30.6
|
20.54
+11.3
YoY
|
-12.3%
+4.3
YoY
|
|
|
SCLXW
Scilex Holding Company
|
-
|
Composite
27.8
Moat
34.4
|
2.27
+1.0
YoY
|
-9.0%
-7.4
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
SHLT
SHL Telemedicine Ltd
|
-
|
Composite
39.4
Moat
28.7
|
-
No YoY
|
-47.2%
-31.4
YoY
|
|
SLRN
ACELYRIN, INC.
|
-
|
Composite
36.0
Moat
94.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
41.8
Moat
34.3
|
6.64
+4.9
YoY
|
-
No YoY
|
|
|
-
|
Composite
50.1
Moat
68.9
|
-
No YoY
|
37.2%
+3.5
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
SRDX
Surmodics, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
SRZNW
Surrozen, Inc. Warrant
|
-
|
Composite
40.7
Moat
59.5
|
35.41
+11.9
YoY
|
-12.1%
-9.7
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
42.1
Moat
25.5
|
-
No YoY
|
-44.9%
+42.1
YoY
|
|
|
-
|
Composite
46.3
Moat
47.5
|
23.22
-50.0
YoY
|
-2.1%
+0.6
YoY
|
|
|
-
|
Composite
29.2
Moat
18.0
|
11.34
+9.8
YoY
|
-65.1%
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
51.8
Moat
56.7
|
-
No YoY
|
-3.1%
+0.5
YoY
|
|
|
-
|
Composite
42.4
Moat
74.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
46.3
Moat
65.2
|
13.62
+11.1
YoY
|
-59.7%
-58.5
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
26.4
Moat
36.5
|
16.38
-6.1
YoY
|
-7.2%
+8.1
YoY
|
|
|
TRML
Tourmaline Bio, Inc.
|
-
|
Composite
44.1
Moat
98.5
|
-
No YoY
|
-
No YoY
|
|
TRVN
Trevena, Inc.
|
-
|
Composite
38.7
Moat
35.6
|
11.98
+3.0
YoY
|
-11.3%
-146.2
YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
TSVT
2seventy bio, Inc.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
44.3
Moat
58.6
|
1.28
-0.3
YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
44.7
Moat
31.5
|
16.15
-14.7
YoY
|
-
No YoY
|
|
|
VRNA
Verona Pharma plc
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
WGSWW
GeneDx Holdings Corp.
|
-
|
Composite
61.9
Moat
55.9
|
59.45
+50.8
YoY
|
-3.1%
+4.5
YoY
|
|
-
|
Composite
65.6
Moat
66.7
|
91.81
-9.6
YoY
|
97.6%
+186.4
YoY
|
|
|
-
|
Composite
65.8
Moat
79.1
|
91.81
-9.6
YoY
|
97.6%
+186.4
YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
|
ZIMV
ZimVie Inc.
|
-
|
Composite
55.4
Moat
56.4
|
-
No YoY
|
-4.6%
+2.2
YoY
|
|
ZOM
Zomedica Corp.
|
-
|
Composite
0.0
Moat
0.0
|
-
No YoY
|
-
No YoY
|
|
ZYXI
Zynex, Inc.
|
-
|
Composite
24.6
Moat
57.1
|
-
No YoY
|
3.1%
-2.7
YoY
|
Sector benchmarks show the distribution of key financial metrics across companies in Healthcare. Use them to contextualise individual company figures against the sector norm. The outer chart band shows the broader distribution, the middle band highlights the typical range, and the markers help separate the median from the average.